{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Diabetes", "Flavonoids", "Mechanism of action", "Medicine", "Metabolic diseases", "Natural products", "Plant species"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38694079", "DateRevised": {"Year": "2024", "Month": "05", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["e29718", "10.1016/j.heliyon.2024.e29718"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "16"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2024", "Month": "May", "Day": "15"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Clinical applications and mechanism insights of natural flavonoids against type 2 diabetes mellitus.", "Pagination": {"StartPage": "e29718", "MedlinePgn": "e29718"}, "Abstract": {"AbstractText": ["Diabetes is a complex disease that affects a large percentage of the world's population, and it is associated with several risk factors. Self-management poses a significant challenge, but natural sources have shown great potential in providing effective glucose reducing solutions. Flavonoids, a class of bioactive substances found in different natural sources including medicinal plants, have emerged as promising candidates in this regard. Indeed, several flavonoids, including apigenin, arbutin, catechins, and cyanidin, have demonstrated remarkable anti-diabetic properties. The clinical effectiveness of these flavonoids is linked to their potential to decrease blood glucose concentration and increase insulin concentration. Thus, the regulation of certain metabolic pathways such as glycolysis and neoglycogenesis has also been demonstrated. <i>In vitro</i> and <i>in vivo</i> investigations revealed different mechanisms of action related to flavonoid compounds at subcellular, cellular, and molecular levels. The main actions reside in the activation of glycolytic signaling pathways and the inhibition of signaling that promotes glucose synthesis and storage. In this review, we highlight the clinical efficiency of natural flavonoids as well as the molecular mechanisms underlying this effectiveness."], "CopyrightInformation": "\u00a9 2024 Published by Elsevier Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco."}, {"Identifier": [], "Affiliation": "Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, 60115 Surabaya, Indonesia."}], "LastName": "Bouyahya", "ForeName": "Abdelhakim", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High Institute of Nursing Professions and Health Techniques of Errachidia, Errachidia, Morocco."}], "LastName": "Balahbib", "ForeName": "Abdelaali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Institute, National Center for Research, P.O. Box: 2424, Khartoum-11111, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Practice Research Unit, Clinical Pharmacy Department, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia."}], "LastName": "Makeen", "ForeName": "Hafiz A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Postal Code 45142, Jazan, Saudi Arabia."}], "LastName": "Alhazmi", "ForeName": "Hassan A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, P.O. Box 114, Postal Code 45142, Jazan, Saudi Arabia."}], "LastName": "Albratty", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, 60115 Surabaya, Indonesia."}], "LastName": "Hermansyah", "ForeName": "Andi", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, 60115 Surabaya, Indonesia."}, {"Identifier": [], "Affiliation": "School of Medical and Life Sciences, Sunway University, Sunway City 47500, Malaysia."}, {"Identifier": [], "Affiliation": "PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong, Brunei Darussalam."}], "LastName": "Ming", "ForeName": "Long Chiau", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Data Science and Information Technology, INTI International University, Nilai, Malaysia."}], "LastName": "Goh", "ForeName": "Khang Wen", "Initials": "KW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High Institute of Nursing Professions and Health Techniques of Tetouan, Tetouan, Morocco."}], "LastName": "El Omari", "ForeName": "Nasreddine", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Al-Ishaq R.K., Abotaleb M., Kubatka P., Kajo K., B\u00fcsselberg D. Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels. Biomolecules. 2019;9:430.", "ArticleIdList": ["PMC6769509", "31480505"]}, {"Citation": "Reynolds M.A. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol. 2014;64:7\u201319. 2000.", "ArticleIdList": ["24320953"]}, {"Citation": "Alemany-Cosme E., S\u00e1ez-Gonz\u00e1lez E., Moret I., Mateos B., Iborra M., Nos P., Sandoval J., Beltr\u00e1n B. Oxidative stress in the pathogenesis of Crohn's disease and the interconnection with immunological response, microbiota, external environmental factors, and epigenetics. Antioxidants. 2021;10:64.", "ArticleIdList": ["PMC7825667", "33430227"]}, {"Citation": "Mellot M., Jawal L., Morel T., Fournier J.-P., Tubach F., Cadwallader J.-S., Christiaens A., Zerah L. Barriers and Enablers for Deprescribing glucose-lowering treatment in older adults: a Systematic review. J. Am. Med. Dir. Assoc. 2024;25:439\u2013447.e18. doi: 10.1016/j.jamda.2023.11.025.", "ArticleIdList": ["10.1016/j.jamda.2023.11.025", "38237904"]}, {"Citation": "Yakary\u0131lmaz F.D., \u00d6zt\u00fcrk Z.A. Treatment of type 2 diabetes mellitus in the elderly. World J. Diabetes. 2017;8:278\u2013285. doi: 10.4239/wjd.v8.i6.278.", "ArticleIdList": ["10.4239/wjd.v8.i6.278", "PMC5483426", "28694928"]}, {"Citation": "Dunstan D.W., Daly R.M., Owen N., Jolley D., De Courten M., Shaw J., Zimmet P. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care. 2002;25:1729\u20131736.", "ArticleIdList": ["12351469"]}, {"Citation": "Castaneda C., Layne J.E., Munoz-Orians L., Gordon P.L., Walsmith J., Foldvari M., Roubenoff R., Tucker K.L., Nelson M.E. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care. 2002;25:2335\u20132341.", "ArticleIdList": ["12453982"]}, {"Citation": "Meyerovitch J., Farfel Z., Sack J., Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J. Biol. Chem. 1987;262:6658\u20136662.", "ArticleIdList": ["2952656"]}, {"Citation": "Rahman S., Rahman T., Ismail A.A.-S., Rashid A.R.A. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes. Metab. 2007;9:767\u2013780.", "ArticleIdList": ["17924861"]}, {"Citation": "Kranstuber A.L., Del Rio C., Biesiadecki B.J., Hamlin R.L., Ottobre J., Gyorke S., Lacombe V.A. Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling. Front. Physiol. 2012;3:292.", "ArticleIdList": ["PMC3429064", "22934044"]}, {"Citation": "Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur. J. Clin. Invest. 2004;34:785\u2013796.", "ArticleIdList": ["15606719"]}, {"Citation": "Scheen A.J. Is there a role for \u03b1-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs. 2003;63:933\u2013951.", "ArticleIdList": ["12699398"]}, {"Citation": "Krishnan V., Rani R., Awana M., Pitale D., Kulshreshta A., Sharma S., Bollinedi H., Singh A., Singh B., Singh A.K. Role of nutraceutical starch and proanthocyanidins of pigmented rice in regulating hyperglycemia: enzyme inhibition, enhanced glucose uptake and hepatic glucose homeostasis using in vitro model. Food Chem. 2021;335", "ArticleIdList": ["32739823"]}, {"Citation": "Williams B.A., Verstegen M.W., Tamminga S. Fermentation in the large intestine of single-stomached animals and its relationship to animal health. Nutr. Res. Rev. 2001;14:207\u2013228.", "ArticleIdList": ["19087424"]}, {"Citation": "Bouche C., Serdy S., Kahn C.R., Goldfine A.B. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr. Rev. 2004;25:807\u2013830.", "ArticleIdList": ["15466941"]}, {"Citation": "Gray L.R., Tompkins S.C., Taylor E.B. Regulation of pyruvate metabolism and human disease. Cell. Mol. Life Sci. 2014;71:2577\u20132604.", "ArticleIdList": ["PMC4059968", "24363178"]}, {"Citation": "Eriksson J.W. Metabolic stress in insulin's target cells leads to ROS accumulation\u2013a hypothetical common pathway causing insulin resistance. FEBS Lett. 2007;581:3734\u20133742.", "ArticleIdList": ["17628546"]}, {"Citation": "Gannon N.P., Schnuck J.K., Vaughan R.A. BCAA metabolism and insulin sensitivity\u2013Dysregulated by metabolic status? Mol. Nutr. Food Res. 2018;62", "ArticleIdList": ["29377510"]}, {"Citation": "Anwer T., Safhi M.M., Makeen H.A., Alshahrani S., Siddiqui R., Sivakumar S.M., Shaheen E.S., Alam M.F. Antidiabetic potential of Moringa oleifera Lam. leaf extract in type 2 diabetic rats, and its mechanism of action. Trop. J. Pharm. Res. 2021;20:95\u2013103. doi: 10.4314/tjpr.v20i1.15.", "ArticleIdList": ["10.4314/tjpr.v20i1.15"]}, {"Citation": "Anwer T., Sharma M., Khan G., Alam M.F., Alam N., Ali M.S., Alam M.S. Preventive role of Withania somnifera on hyperlipidemia and cardiac oxidative stress in streptozotocin induced type 2 diabetic rats. Trop. J. Pharm. Res. 2017;16:119\u2013125. doi: 10.4314/tjpr.v16i1.15.", "ArticleIdList": ["10.4314/tjpr.v16i1.15"]}, {"Citation": "Moni S.S., Alam M.F., Makeen H.A., Jabeen A., Sanobar S., Siddiqui R., Moochikkal R., Fouda S. Therapeutic potential of oleic acid nanovesicles prepared from petroleum ether extract of Sargassum binderi in streptozotocin\u2013induced diabetic wound in Wistar rats. Trop. J. Pharm. Res. 2018;17:2123\u20132128. doi: 10.4314/tjpr.v17i11.2.", "ArticleIdList": ["10.4314/tjpr.v17i11.2"]}, {"Citation": "Zafar A., Alruwaili N.K., Panda D.S., Imam S.S., Alharbi K.S., Afzal M., Shalaby K., Kazmi I., Alshehri S. Potential of natural bioactive compounds in management of diabetes: review of preclinical and clinical evidence. Curr. Pharmacol. Rep. 2021;7:107\u2013122."}, {"Citation": "Fatiha M., Fatma B., Awatif B., Nesrine A., Noureddine D. Antidiabetic bioactive compounds from plants, Med. Technol. J. 2018;2:199\u2013214."}, {"Citation": "Yogeswari S., Bindu K.H., Kamalraj S., Ashokkumar V., Jayabaskaran C. Antidiabetic, Antithrombin and Cytotoxic bioactive compounds in five cultivars of Piper betle L. Environ. Technol. Innov. 2020;20"}, {"Citation": "Agarwal S., Singh V., Chauhan K. Antidiabetic potential of seaweed and their bioactive compounds: a review of developments in last decade. Crit. Rev. Food Sci. Nutr. 2021:1\u201332.", "ArticleIdList": ["35048763"]}, {"Citation": "Bouyahya A., El Omari N., Elmenyiy N., Guaouguaou F.-E., Balahbib A., Belmehdi O., Salhi N., Imtara H., Mrabti H.N., El-Shazly M. Moroccan antidiabetic medicinal plants: Ethnobotanical studies, phytochemical bioactive compounds, preclinical investigations, toxicological validations and clinical evidences; challenges, guidance and perspectives for future management of diabetes worldwide. Trends Food Sci. Technol. 2021;115:147\u2013254."}, {"Citation": "Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomed. Pharmacother. 2017;96:305\u2013312.", "ArticleIdList": ["29017142"]}, {"Citation": "Savych A., Milian I. Total flavonoid content in the herbal mixture with antidiabetic activity. Pharmacologyonline. 2021;2:68\u201375."}, {"Citation": "Xiao J., Capanoglu E., Jassbi A.R., Miron A. Advance on the flavonoid C-glycosides and health benefits. Crit. Rev. Food Sci. Nutr. 2016;56:S29\u2013S45.", "ArticleIdList": ["26462718"]}, {"Citation": "Brasny\u00f3 P., Moln\u00e1r G.A., Moh\u00e1s M., Mark\u00f3 L., Laczy B., Cseh J., Mikol\u00e1s E., Szij\u00e1rt\u00f3 I.A., M\u00e9rei \u00c1., Halmai R., M\u00e9sz\u00e1ros L.G., S\u00fcmegi B., Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011;106:383\u2013389. doi: 10.1017/S0007114511000316.", "ArticleIdList": ["10.1017/S0007114511000316", "21385509"]}, {"Citation": "Bhatt J.K., Thomas S., Nanjan M.J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 2012;32:537\u2013541. doi: 10.1016/j.nutres.2012.06.003.", "ArticleIdList": ["10.1016/j.nutres.2012.06.003", "22901562"]}, {"Citation": "Yoshino J., Conte C., Fontana L., Mittendorfer B., Imai S., Schechtman K.B., Gu C., Kunz I., Fanelli F.R., Patterson B.W., Klein S. Resveratrol supplementation does not improve metabolic function in Nonobese women with normal glucose tolerance. Cell Metabol. 2012;16:658\u2013664. doi: 10.1016/j.cmet.2012.09.015.", "ArticleIdList": ["10.1016/j.cmet.2012.09.015", "PMC3496026", "23102619"]}, {"Citation": "Movahed A., Nabipour I., Lieben Louis X., Thandapilly S.J., Yu L., Kalantarhormozi M., Rekabpour S.J., Netticadan T. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid. Based Complement. Alternat. Med. 2013;2013:1\u201311. doi: 10.1155/2013/851267.", "ArticleIdList": ["10.1155/2013/851267", "PMC3773903", "24073011"]}, {"Citation": "M\u00e9ndez-del Villar M., Gonz\u00e1lez-Ortiz M., Mart\u00ednez-Abundis E., P\u00e9rez-Rubio K.G., Liz\u00e1rraga-Valdez R. Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab. Syndr. Relat. Disord. 2014;12:497\u2013501. doi: 10.1089/met.2014.0082.", "ArticleIdList": ["10.1089/met.2014.0082", "25137036"]}, {"Citation": "Williams C.B., Hughes M.C., Edgett B.A., Scribbans T.D., Simpson C.A., Perry C.G.R., Gurd B.J. An Examination of Resveratrol's mechanisms of action in human tissue: impact of a single dose in vivo and dose responses in skeletal muscle ex vivo. PLoS One. 2014;9 doi: 10.1371/journal.pone.0102406.", "ArticleIdList": ["10.1371/journal.pone.0102406", "PMC4096915", "25019209"]}, {"Citation": "Chen S., Zhao X., Ran L., Wan J., Wang X., Qin Y., Shu F., Gao Y., Yuan L., Zhang Q., Mi M. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig. Liver Dis. 2015;47:226\u2013232. doi: 10.1016/j.dld.2014.11.015.", "ArticleIdList": ["10.1016/j.dld.2014.11.015", "25577300"]}, {"Citation": "Thazhath S.S., Wu T., Bound M.J., Checklin H.L., Standfield S., Jones K.L., Horowitz M., Rayner C.K. Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. Am. J. Clin. Nutr. 2016;103:66\u201370. doi: 10.3945/ajcn.115.117440.", "ArticleIdList": ["10.3945/ajcn.115.117440", "26607942"]}, {"Citation": "Banaszewska B., Wroty\u0144ska-Barczy\u0144ska J., Spaczynski R.Z., Pawelczyk L., Duleba A.J. Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2016;101:4322\u20134328. doi: 10.1210/jc.2016-1858.", "ArticleIdList": ["10.1210/jc.2016-1858", "27754722"]}, {"Citation": "Most J., Timmers S., Warnke I., Jocken J.W., van Boekschoten M., de Groot P., Bendik I., Schrauwen P., Goossens G.H., Blaak E.E. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial. Am. J. Clin. Nutr. 2016;104:215\u2013227. doi: 10.3945/ajcn.115.122937.", "ArticleIdList": ["10.3945/ajcn.115.122937", "27194304"]}, {"Citation": "Timmers S., de Ligt M., Phielix E., van de Weijer T., Hansen J., Moonen-Kornips E., Schaart G., Kunz I., Hesselink M.K.C., Schrauwen-Hinderling V.B., Schrauwen P. Resveratrol as Add-on therapy in subjects with well-controlled type 2 diabetes: a randomized controlled trial. Diabetes Care. 2016;39:2211\u20132217. doi: 10.2337/dc16-0499.", "ArticleIdList": ["10.2337/dc16-0499", "27852684"]}, {"Citation": "Kj\u00e6r T.N., Ornstrup M.J., Poulsen M.M., St\u00f8dkilde-J\u00f8rgensen H., Jessen N., J\u00f8rgensen J.O.L., Richelsen B., Pedersen S.B. No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 2017;102:1642\u20131651. doi: 10.1210/jc.2016-2160.", "ArticleIdList": ["10.1210/jc.2016-2160", "28182820"]}, {"Citation": "Made S., Plat J., Mensink R. Trans-resveratrol supplementation and endothelial function during the fasting and postprandial Phase: a randomized placebo-controlled trial in overweight and slightly obese participants. Nutrients. 2017;9:596. doi: 10.3390/nu9060596.", "ArticleIdList": ["10.3390/nu9060596", "PMC5490575", "28604618"]}, {"Citation": "de Ligt M., Bruls Y.M.H., Hansen J., Habets M.-F., Havekes B., Nascimento E.B.M., Moonen-Kornips E., Schaart G., Schrauwen-Hinderling V.B., van Marken Lichtenbelt W., Schrauwen P. Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Mol. Metab. 2018;12:39\u201347. doi: 10.1016/j.molmet.2018.04.004.", "ArticleIdList": ["10.1016/j.molmet.2018.04.004", "PMC6001939", "29706321"]}, {"Citation": "Ma N., Zhang Y. Effects of resveratrol therapy on glucose metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: a randomized controlled clinical trial protocol. Medicine (Baltim.) 2022;101", "ArticleIdList": ["PMC9371579", "35960095"]}, {"Citation": "Mahjabeen W., Khan D.A., Mirza S.A. Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: a randomized, placebo-controlled trial, Complement. Ther. Med. 2022;66", "ArticleIdList": ["35240291"]}, {"Citation": "Nagao T., Meguro S., Hase T., Otsuka K., Komikado M., Tokimitsu I., Yamamoto T., Yamamoto K. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity. 2009;17:310\u2013317. doi: 10.1038/oby.2008.505.", "ArticleIdList": ["10.1038/oby.2008.505", "19008868"]}, {"Citation": "Takahashi M., Miyashita M., Suzuki K., Bae S., Kim H.-K., Wakisaka T., Matsui Y., Takeshita M., Yasunaga K. Acute ingestion of catechin-rich green tea improves postprandial glucose status and increases serum thioredoxin concentrations in postmenopausal women. Br. J. Nutr. 2014;112:1542\u20131550. doi: 10.1017/S0007114514002530.", "ArticleIdList": ["10.1017/S0007114514002530", "25230741"]}, {"Citation": "Bazyar H., Moradi L., Zaman F., Zare Javid A. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: a double-blind, placebo-controlled trial. Phytother Res. 2022;37:271\u2013284.", "ArticleIdList": ["36101997"]}, {"Citation": "Hashizume Y., Tandia M. Suppressive effect of a single dose of monoglucosyl rutin on postprandial blood glucose elevation: a randomized, placebo-controlled, double-blind crossover study, Funct. Foods Health Dis. 2021;11:270\u2013282."}, {"Citation": "Dower J.I., Geleijnse J.M., Gijsbers L., Zock P.L., Kromhout D., Hollman P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015;101:914\u2013921. doi: 10.3945/ajcn.114.098590.", "ArticleIdList": ["10.3945/ajcn.114.098590", "25934864"]}, {"Citation": "Rizvi S.I., Zaid M.A. Insulin-like effect of (-)Epicatechin on Erythrocyte membrane Acetylcholinesterase activity in type 2 diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 2001;28:776\u2013778. doi: 10.1046/j.1440-1681.2001.03513.x.", "ArticleIdList": ["10.1046/j.1440-1681.2001.03513.x", "11553037"]}, {"Citation": "Osama H., Hamed E.O., Mahmoud M.A., Abdelrahim M.E. The effect of hesperidin and diosmin individually or in combination on metabolic profile and neuropathy among diabetic patients with metabolic syndrome: a randomized controlled trial. J. Diet. Suppl. 2022:1\u201314.", "ArticleIdList": ["35946912"]}, {"Citation": "Yamagata K., Miyashita A., Chino M., Matsufuji H. Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells. Microvasc. Res. 2011;81:60\u201367. doi: 10.1016/j.mvr.2010.10.005.", "ArticleIdList": ["10.1016/j.mvr.2010.10.005", "21040737"]}, {"Citation": "Yamagata K., Miyashita A., Matsufuji H., Chino M. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor \u03b1-induced adhesion molecule expression in human endothelial cells. J. Nutr. Biochem. 2010;21:116\u2013124. doi: 10.1016/j.jnutbio.2008.11.003.", "ArticleIdList": ["10.1016/j.jnutbio.2008.11.003", "19195861"]}, {"Citation": "Zeng L., Zhang G., Lin S., Gong D. Inhibitory mechanism of apigenin on \u03b1-glucosidase and Synergy analysis of flavonoids. J. Agric. Food Chem. 2016;64:6939\u20136949. doi: 10.1021/acs.jafc.6b02314.", "ArticleIdList": ["10.1021/acs.jafc.6b02314", "27581205"]}, {"Citation": "Sahnoun M., Saibi W., Brini F., Bejar S. Apigenin isolated from A. americana encodes Human and Aspergillus oryzae S2 \u03b1-amylase inhibitions: credible approach for antifungal and antidiabetic therapies. J. Food Sci. Technol. 2018;55:1489\u20131498. doi: 10.1007/s13197-018-3065-6.", "ArticleIdList": ["10.1007/s13197-018-3065-6", "PMC5876219", "29606763"]}, {"Citation": "Yousefi F., Mahjoub S., Pouramir M., Khadir F. Hypoglycemic activity of Pyrus biossieriana Buhse leaf extract and arbutin: inhibitory effects on alpha amylase and alpha glucosidase. Casp. J. Intern. Med. 2013;4:763.", "ArticleIdList": ["PMC3841776", "24294470"]}, {"Citation": "Gholami Bahnemiri M., Nouri H.R., Zabihi E., Sadeghi F., Pouramir M. Effects of arbutin on glucose uptake by glucose transporter 4 (GLUT4) and its cytoprotective properties in L6 skeletal muscle cell line. Cell Biochem. Funct. 2022;40:417\u2013425.", "ArticleIdList": ["35575602"]}, {"Citation": "Fang P., Yu M., Zhang L., Wan D., Shi M., Zhu Y., Bo P., Zhang Z. Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway. Mol. Cell. Endocrinol. 2017;448:77\u201386. doi: 10.1016/j.mce.2017.03.027.", "ArticleIdList": ["10.1016/j.mce.2017.03.027", "28359800"]}, {"Citation": "Fang P., Yu M., Min W., Han S., Shi M., Zhang Z., Bo P. Beneficial effect of baicalin on insulin sensitivity in adipocytes of diet-induced obese mice. Diabetes Res. Clin. Pract. 2018;139:262\u2013271. doi: 10.1016/j.diabres.2018.03.007.", "ArticleIdList": ["10.1016/j.diabres.2018.03.007", "29526684"]}, {"Citation": "Fang P., Sun Y., Gu X., Shi M., Bo P., Zhang Z., Bu L. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1\u03b1 pathway. Phytomedicine. 2019;64 doi: 10.1016/j.phymed.2019.153074.", "ArticleIdList": ["10.1016/j.phymed.2019.153074", "31473580"]}, {"Citation": "Yu M., Han S., Wang M., Han L., Huang Y., Bo P., Fang P., Zhang Z. Baicalin protects against insulin resistance and metabolic dysfunction through activation of GALR2/GLUT4 signaling. Phytomedicine. 2022;95 doi: 10.1016/j.phymed.2021.153869.", "ArticleIdList": ["10.1016/j.phymed.2021.153869", "34923235"]}, {"Citation": "Miao L., Zhang X., Zhang H., Cheong M.S., Chen X., Farag M.A., Cheang W.S., Xiao J. Baicalin ameliorates insulin resistance and regulates hepatic glucose metabolism via activating insulin signaling pathway in obese pre-diabetic mice. Phytomedicine. 2024;124 doi: 10.1016/j.phymed.2023.155296.", "ArticleIdList": ["10.1016/j.phymed.2023.155296", "38176276"]}, {"Citation": "Shimizu M., Kobayashi Y., Suzuki M., Satsu H., Miyamoto Y. Regulation of intestinal glucose transport by tea catechins. Biofactors. 2000;13:61\u201365. doi: 10.1002/biof.5520130111.", "ArticleIdList": ["10.1002/biof.5520130111", "11237201"]}, {"Citation": "Matsui T., Tanaka T., Tamura S., Toshima A., Tamaya K., Miyata Y., Tanaka K., Matsumoto K. \u03b1-Glucosidase inhibitory profile of catechins and theaflavins. J. Agric. Food Chem. 2007;55:99\u2013105. doi: 10.1021/jf0627672.", "ArticleIdList": ["10.1021/jf0627672", "17199319"]}, {"Citation": "Murase T., Misawa K., Haramizu S., Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem. Pharmacol. 2009;78:78\u201384. doi: 10.1016/j.bcp.2009.03.021.", "ArticleIdList": ["10.1016/j.bcp.2009.03.021", "19447226"]}, {"Citation": "Kamiyama O., Sanae F., Ikeda K., Higashi Y., Minami Y., Asano N., Adachi I., Kato A. In vitro inhibition of \u03b1-glucosidases and glycogen phosphorylase by catechin gallates in green tea. Food Chem. 2010;122:1061\u20131066. doi: 10.1016/j.foodchem.2010.03.075.", "ArticleIdList": ["10.1016/j.foodchem.2010.03.075"]}, {"Citation": "Yilmazer-Musa M., Griffith A.M., Michels A.J., Schneider E., Frei B. Grape seed and tea extracts and catechin 3-gallates are potent inhibitors of \u03b1-amylase and \u03b1-glucosidase activity. J. Agric. Food Chem. 2012;60:8924\u20138929. doi: 10.1021/jf301147n.", "ArticleIdList": ["10.1021/jf301147n", "PMC4356113", "22697360"]}, {"Citation": "Xu Y., Zhang Z., Li L., Joshi M.K., Huang N., Niu J., Lu Y. Catechins play key role in green tea extract\u2013induced postprandial hypoglycemic potential in vitro. Eur. Food Res. Technol. 2013;237:89\u201399. doi: 10.1007/s00217-013-1945-6.", "ArticleIdList": ["10.1007/s00217-013-1945-6"]}, {"Citation": "Sun L., Song Y., Chen Y., Ma Y., Fu M., Liu X. The galloyl moiety enhances the inhibitory activity of catechins and theaflavins against \u03b1-glucosidase by increasing the polyphenol\u2013enzyme binding interactions. Food Funct. 2021;12:215\u2013229.", "ArticleIdList": ["33295908"]}, {"Citation": "Mechchate H., Es-Safi I., Haddad H., Bekkari H., Grafov A., Bousta D. Combination of Catechin, Epicatechin, and Rutin: optimization of a novel complete antidiabetic formulation using a mixture design approach. J. Nutr. Biochem. 2021;88", "ArticleIdList": ["33017607"]}, {"Citation": "Taslimi P., Kocyigit U.M., T\u00fcz\u00fcn B., Kirici M. Biological effects and molecular docking studies of Catechin 5-O-gallate: antioxidant, anticholinergics, antiepileptic and antidiabetic potentials. J. Biomol. Struct. Dyn. 2022;40:2489\u20132497.", "ArticleIdList": ["33146092"]}, {"Citation": "Adisakwattana S., Ngamrojanavanich N., Kalampakorn K., Tiravanit W., Roengsumran S., Yibchok-Anun S. Inhibitory activity of cyanidin-3-rutinoside on \u03b1-glucosidase. J. Enzyme Inhib. Med. Chem. 2004;19:313\u2013316. doi: 10.1080/14756360409162443.", "ArticleIdList": ["10.1080/14756360409162443", "15558946"]}, {"Citation": "Adisakwattana S., Charoenlertkul P., Yibchok-anun S. \u03b1-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose. J. Enzyme Inhib. Med. Chem. 2009;24:65\u201369. doi: 10.1080/14756360801906947.", "ArticleIdList": ["10.1080/14756360801906947", "18615280"]}, {"Citation": "Akkarachiyasit S., Charoenlertkul P., Yibchok-anun S., Adisakwattana S. Inhibitory activities of cyanidin and its glycosides and synergistic effect with acarbose against intestinal \u03b1-glucosidase and pancreatic \u03b1-amylase. Int. J. Mol. Sci. 2010;11:3387\u20133396. doi: 10.3390/ijms11093387.", "ArticleIdList": ["10.3390/ijms11093387", "PMC2956102", "20957102"]}, {"Citation": "Adisakwattana S., Yibchok-Anun S., Charoenlertkul P., Wongsasiripat N. Cyanidin-3-rutinoside alleviates postprandial hyperglycemia and its synergism with acarbose by inhibition of intestinal \u03b1-glucosidase. J. Clin. Biochem. Nutr. 2011;49:36\u201341.", "ArticleIdList": ["PMC3128364", "21765605"]}, {"Citation": "Inaguma T., Han J., Isoda H. Improvement of insulin resistance by Cyanidin 3-glucoside, anthocyanin from black beans through the up-regulation of GLUT4 gene expression. BMC Proc. 2011;5:P21. doi: 10.1186/1753-6561-5-S8-P21.", "ArticleIdList": ["10.1186/1753-6561-5-S8-P21", "PMC3284935", "22373152"]}, {"Citation": "Scazzocchio B., Vari R., Filesi C., D'Archivio M., Santangelo C., Giovannini C., Iacovelli A., Silecchia G., Volti G.L., Galvano F., Masella R. Cyanidin-3-O- -glucoside and protocatechuic acid exert insulin-like effects by upregulating PPAR activity in human Omental adipocytes. Diabetes. 2011;60:2234\u20132244. doi: 10.2337/db10-1461.", "ArticleIdList": ["10.2337/db10-1461", "PMC3161313", "21788573"]}, {"Citation": "Lee J.S., Kim Y.R., Park J.M., Kim Y.E., Baek N.I., Hong E.K. Cyanidin-3-glucoside isolated from mulberry fruits protects pancreatic \u03b2-cells against glucotoxicity-induced apoptosis. Mol. Med. Rep. 2015;11:2723\u20132728. doi: 10.3892/mmr.2014.3078.", "ArticleIdList": ["10.3892/mmr.2014.3078", "25501967"]}, {"Citation": "Lee J.S., Kim Y.R., Song I.G., Ha S.-J., Kim Y.E., Baek N.-I., Hong E.K. Cyanidin-3-glucoside isolated from mulberry fruit protects pancreatic \u03b2-cells against oxidative stress-induced apoptosis. Int. J. Mol. Med. 2015;35:405\u2013412. doi: 10.3892/ijmm.2014.2013.", "ArticleIdList": ["10.3892/ijmm.2014.2013", "25435295"]}, {"Citation": "Matsukawa T., Inaguma T., Han J., Villareal M.O., Isoda H. Cyanidin-3-glucoside derived from black soybeans ameliorate type 2 diabetes through the induction of differentiation of preadipocytes into smaller and insulin-sensitive adipocytes. J. Nutr. Biochem. 2015;26:860\u2013867. doi: 10.1016/j.jnutbio.2015.03.006.", "ArticleIdList": ["10.1016/j.jnutbio.2015.03.006", "25940979"]}, {"Citation": "Talagavadi V., Rapisarda P., Galvano F., Pelicci P., Giorgio M. Cyanidin-3- O -\u03b2-glucoside and protocatechuic acid activate AMPK/mTOR/S6K pathway and improve glucose homeostasis in mice. J. Funct.Foods. 2016;21:338\u2013348. doi: 10.1016/j.jff.2015.12.007.", "ArticleIdList": ["10.1016/j.jff.2015.12.007"]}, {"Citation": "Choi Kyungha, Choi S.-I., Park M.H., Han J.-S. Cyanidin-3-O-glucoside ameliorates postprandial hyperglycemia in diabetic mice. J. Life Sci. 2017;27:32\u201337. doi: 10.5352/JLS.2017.27.1.32.", "ArticleIdList": ["10.5352/JLS.2017.27.1.32"]}, {"Citation": "Choi Kyungha, Lee H.A., Park M.H., Han J.-S. Cyanidin-3-rutinoside increases glucose uptake by activating the PI3K/Akt pathway in 3T3-L1 adipocytes. Environ. Toxicol. Pharmacol. 2017;54:1\u20136. doi: 10.1016/j.etap.2017.06.007.", "ArticleIdList": ["10.1016/j.etap.2017.06.007", "28667861"]}, {"Citation": "Suantawee T., Elazab S., Hsu W., Yao S., Cheng H., Adisakwattana S. Cyanidin stimulates insulin secretion and pancreatic \u03b2-cell gene expression through activation of l-type voltage-dependent Ca2+ channels. Nutrients. 2017;9:814. doi: 10.3390/nu9080814.", "ArticleIdList": ["10.3390/nu9080814", "PMC5579608", "28788070"]}, {"Citation": "C\u00e1sedas G., Les F., Gonz\u00e1lez-Burgos E., G\u00f3mez-Serranillos M.P., Smith C., L\u00f3pez V. Cyanidin-3-O-glucoside inhibits different enzymes involved in central nervous system pathologies and type-2 diabetes, South Afr. J. Bot., Le. 2019;120:241\u2013246. doi: 10.1016/j.sajb.2018.07.001.", "ArticleIdList": ["10.1016/j.sajb.2018.07.001"]}, {"Citation": "Fraisse D., Bred A., Felgines C., Senejoux F. Impact of simulated gastrointestinal conditions on antiglycoxidant and \u03b1-glucosidase inhibition capacities of cyanidin-3-O-glucoside. Antioxidants. 2021;10:1670.", "ArticleIdList": ["PMC8614994", "34829542"]}, {"Citation": "Jia Y., Wu C., Rivera-Piza A., Kim Y.-J., Lee J.H., Lee S.-J. Mechanism of action of cyanidin 3-O-glucoside in gluconeogenesis and oxidative stress-induced cancer cell senescence. Antioxidants. 2022;11:749.", "ArticleIdList": ["PMC9029247", "35453434"]}, {"Citation": "Ye X., Chen W., Tu P., Jia R., Liu Y., Tang Q., Chen C., Yang C., Zheng X., Chu Q. Antihyperglycemic effect of an anthocyanin, cyanidin-3-O-glucoside, is achieved by regulating GLUT-1 via the Wnt/\u03b2-catenin-WISP1 signaling pathway. Food Funct. 2022;13:4612\u20134623.", "ArticleIdList": ["35357376"]}, {"Citation": "Kongthitilerd P., Thilavech T., Marnpae M., Rong W., Yao S., Adisakwattana S., Cheng H., Sauntawee T. Cyanidin-3-rutinoside stimulated insulin secretion through activation of L-type voltage-dependent Ca2+ channels and the PLC-IP3 pathway in pancreatic \u03b2-cells, Biomed. Pharmacother. 2022;146", "ArticleIdList": ["34891116"]}, {"Citation": "Jayaprakasam B., Vareed S.K., Olson L.K., Nair M.G. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 2005;53:28\u201331.", "ArticleIdList": ["15631504"]}, {"Citation": "Rojo L.E., Ribnicky D., Logendra S., Poulev A., Rojas-Silva P., Kuhn P., Dorn R., Grace M.H., Lila M.A., Raskin I. In vitro and in vivo anti-diabetic effects of anthocyanins from Maqui Berry (Aristotelia chilensis) Food Chem. 2012;131:387\u2013396. doi: 10.1016/j.foodchem.2011.08.066.", "ArticleIdList": ["10.1016/j.foodchem.2011.08.066", "PMC4535716", "26279603"]}, {"Citation": "Hidalgo J., Teuber S., Morera F., Ojeda C., Flores C., Hidalgo M., N\u00fa\u00f1ez L., Villalobos C., Burgos R. Delphinidin reduces glucose uptake in mice jejunal tissue and human intestinal cells lines through FFA1/GPR40. Int. J. Mol. Sci. 2017;18:750. doi: 10.3390/ijms18040750.", "ArticleIdList": ["10.3390/ijms18040750", "PMC5412335", "28379159"]}, {"Citation": "Mojica L., Berhow M., Gonzalez de Mejia E. Food Chem. 2017;229:628\u2013639. doi: 10.1016/j.foodchem.2017.02.124.", "ArticleIdList": ["10.1016/j.foodchem.2017.02.124", "28372224"]}, {"Citation": "Lai D., Huang M., Zhao L., Tian Y., Li Y., Liu D., Wu Y., Deng F. Delphinidin-induced autophagy protects pancreatic \u03b2 cells against apoptosis resulting from high-glucose stress via AMPK signaling pathway. Acta Biochim. Biophys. Sin. 2019;51:1242\u20131249. doi: 10.1093/abbs/gmz126.", "ArticleIdList": ["10.1093/abbs/gmz126", "31781740"]}, {"Citation": "Hii C.S., Howell S.L. Effects of epicatechin on rat islets of Langerhans. Diabetes. 1984;33:291\u2013296.", "ArticleIdList": ["6365662"]}, {"Citation": "Ahmad F., Khalid P., Khan M.M., Rastogi A.K., Kidwai J.R. Insulin like activity in (\u2212) epicatechin. Acta Diabetol. Lat. 1989;26:291\u2013300.", "ArticleIdList": ["2698039"]}, {"Citation": "Ahmad F. Effect of (-) epicatechin on cAMP content, insulin release and conversion of proinsulin to insulin in immature and mature rat islets in vitro. Indian J. Exp. Biol. 1991;29:516\u2013520.", "ArticleIdList": ["1653764"]}, {"Citation": "Kim M.-J., Ryu G.R., Chung J.-S., Sim S.S., Min D.S., Rhie D.-J., Yoon S.H., Hahn S.J., Kim M.-S., Jo Y.-H. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas. 2003;26:292\u2013299. doi: 10.1097/00006676-200304000-00014.", "ArticleIdList": ["10.1097/00006676-200304000-00014", "12657957"]}, {"Citation": "Mart\u00edn M.\u00c1., Fern\u00e1ndez-Mill\u00e1n E., Ramos S., Bravo L., Goya L. Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol. Nutr. Food Res. 2014;58:447\u2013456. doi: 10.1002/mnfr.201300291.", "ArticleIdList": ["10.1002/mnfr.201300291", "24115486"]}, {"Citation": "Ueda-Wakagi M., Mukai R., Fuse N., Mizushina Y., Ashida H. 3-O-Acyl-epicatechins increase glucose uptake activity and GLUT4 translocation through activation of PI3K signaling in skeletal muscle cells. Int. J. Mol. Sci. 2015;16:16288\u201316299. doi: 10.3390/ijms160716288.", "ArticleIdList": ["10.3390/ijms160716288", "PMC4519950", "26193264"]}, {"Citation": "Liu Z.-H., Li B. (-)-Epicatechin and \u03b2-glucan from highland barley grain modulated glucose metabolism and showed synergistic effect via Akt pathway. J. Funct.Foods. 2021;87"}, {"Citation": "Yoshida H., Takamura N., Shuto T., Ogata K., Tokunaga J., Kawai K., Kai H. The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-\u03b1 in mouse adipocytes. Biochem. Biophys. Res. Commun. 2010;394:728\u2013732. doi: 10.1016/j.bbrc.2010.03.060.", "ArticleIdList": ["10.1016/j.bbrc.2010.03.060", "20230793"]}, {"Citation": "Gong Y., Qin X.-Y., Zhai Y.-Y., Hao H., Lee J., Park Y.-D. Inhibitory effect of hesperetin on \u03b1-glucosidase: molecular dynamics simulation integrating inhibition kinetics. Int. J. Biol. Macromol. 2017;101:32\u201339. doi: 10.1016/j.ijbiomac.2017.03.072.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.03.072", "28322965"]}, {"Citation": "Chae B.S., Shin T.Y. Articels: hesperidin ameliorates TNF-\u03b1-mediated insulin resistance in differentiated 3T3-L1 cells. Nat. Prod. Sci. 2012;18:254\u2013260."}, {"Citation": "Fang X.-K., Gao J., Zhu D.-N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008;82:615\u2013622. doi: 10.1016/j.lfs.2007.12.021.", "ArticleIdList": ["10.1016/j.lfs.2007.12.021", "18262572"]}, {"Citation": "Lee Y.J., Suh K.S., Choi M.C., Chon S., Oh S., Woo J.-T., Kim S.-W., Kim J.-W., Kim Y.S. Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage. Phytother Res. 2010;24:419\u2013423. doi: 10.1002/ptr.2983.", "ArticleIdList": ["10.1002/ptr.2983", "19827031"]}, {"Citation": "Habtemariam S. \u03b1-Glucosidase inhibitory activity of kaempferol-3-O-rutinoside. Nat. Prod. Commun. 2011;6 doi: 10.1177/1934578X1100600211.", "ArticleIdList": ["10.1177/1934578X1100600211", "21425674"]}, {"Citation": "Zhang Y., Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur. J. Pharmacol. 2011;670:325\u2013332. doi: 10.1016/j.ejphar.2011.08.011.", "ArticleIdList": ["10.1016/j.ejphar.2011.08.011", "21914439"]}, {"Citation": "Zhang Y., Zhen W., Maechler P., Liu D. Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic \u03b2-cell survival and function via CREB. J. Nutr. Biochem. 2013;24:638\u2013646. doi: 10.1016/j.jnutbio.2012.03.008.", "ArticleIdList": ["10.1016/j.jnutbio.2012.03.008", "PMC3654796", "22819546"]}, {"Citation": "Li H., Ji H.-S., Kang J.-H., Shin D.-H., Park H.-Y., Choi M.-S., Lee C.-H., Lee I.-K., Yun B.-S., Jeong T.-S. Soy leaf extract containing kaempferol glycosides and pheophorbides improves glucose homeostasis by enhancing pancreatic \u03b2-cell function and suppressing hepatic lipid accumulation in db/db mice. J. Agric. Food Chem. 2015;63:7198\u20137210. doi: 10.1021/acs.jafc.5b01639.", "ArticleIdList": ["10.1021/acs.jafc.5b01639", "26211813"]}, {"Citation": "Peng X., Zhang G., Liao Y., Gong D. Inhibitory kinetics and mechanism of kaempferol on \u03b1-glucosidase. Food Chem. 2016;190:207\u2013215. doi: 10.1016/j.foodchem.2015.05.088.", "ArticleIdList": ["10.1016/j.foodchem.2015.05.088", "26212963"]}, {"Citation": "Ibitoye O.B., Uwazie J.N., Ajiboye T.O. Bioactivity-guided isolation of kaempferol as the antidiabetic principle from Cucumis sativus L. fruits. J. Food Biochem. 2018;42 doi: 10.1111/jfbc.12479.", "ArticleIdList": ["10.1111/jfbc.12479"]}, {"Citation": "Sheng Z., Ai B., Zheng L., Zheng X., Xu Z., Shen Y., Jin Z. Inhibitory activities of kaempferol, galangin, carnosic acid and polydatin against glycation and \u03b1-amylase and \u03b1-glucosidase enzymes. Int. J. Food Sci. Technol. 2018;53:755\u2013766. doi: 10.1111/ijfs.13579.", "ArticleIdList": ["10.1111/ijfs.13579"]}, {"Citation": "Varshney R., Gupta S., Roy P. Cytoprotective effect of kaempferol against palmitic acid-induced pancreatic \u03b2-cell death through modulation of autophagy via AMPK/mTOR signaling pathway. Mol. Cell. Endocrinol. 2017;448:1\u201320. doi: 10.1016/j.mce.2017.02.033.", "ArticleIdList": ["10.1016/j.mce.2017.02.033", "28237721"]}, {"Citation": "Yin P., Yang L., Xue Q., Yu M., Yao F., Sun L., Liu Y. Identification and inhibitory activities of ellagic acid- and kaempferol-derivatives from Mongolian oak cups against \u03b1-glucosidase, \u03b1-amylase and protein glycation linked to type II diabetes and its complications and their influence on HepG2 cells' viability. Arab. J. Chem. 2018;11:1247\u20131259. doi: 10.1016/j.arabjc.2017.10.002.", "ArticleIdList": ["10.1016/j.arabjc.2017.10.002"]}, {"Citation": "Kim J.-S., Kwon C.-S., SoN K.H. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem. 2000;64:2458\u20132461.", "ArticleIdList": ["11193416"]}, {"Citation": "Matsui T., Kobayashi M., Hayashida S., Matsumoto K. Luteolin, a flavone, does not suppress postprandial glucose absorption through an inhibition of \u03b1-glucosidase action. Biosci. Biotechnol. Biochem. 2002;66:689\u2013692. doi: 10.1271/bbb.66.689.", "ArticleIdList": ["10.1271/bbb.66.689", "12005074"]}, {"Citation": "Ding L., Jin D., Chen X. Luteolin enhances insulin sensitivity via activation of PPAR\u03b3 transcriptional activity in adipocytes. J. Nutr. Biochem. 2010;21:941\u2013947. doi: 10.1016/j.jnutbio.2009.07.009.", "ArticleIdList": ["10.1016/j.jnutbio.2009.07.009", "19954946"]}, {"Citation": "Deqiu Z., Kang L., Jiali Y., Baolin L., Gaolin L. Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium. Biochimie. 2011;93:506\u2013512. doi: 10.1016/j.biochi.2010.11.002.", "ArticleIdList": ["10.1016/j.biochi.2010.11.002", "21081149"]}, {"Citation": "Choi Jae Sue, Islam MdN., Ali MdY., Kim Y.M., Park H.J., Sohn H.S., Jung H.A. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer\u2019s disease, anti-diabetic, and anti-inflammatory activities. Arch Pharm. Res. (Seoul) 2014;37:1354\u20131363. doi: 10.1007/s12272-014-0351-3.", "ArticleIdList": ["10.1007/s12272-014-0351-3", "24988985"]}, {"Citation": "Ding Y., Shi X., Shuai X., Xu Y., Liu Y., Liang X., Wei D., Su D. Luteolin prevents uric acid-induced pancreatic \u03b2-cell dysfunction. J. Biomed. Res. 2014;28:292.", "ArticleIdList": ["PMC4102843", "25050113"]}, {"Citation": "Yan J., Zhang G., Pan J., Wang Y. \u03b1-Glucosidase inhibition by luteolin: kinetics, interaction and molecular docking. Int. J. Biol. Macromol. 2014;64:213\u2013223. doi: 10.1016/j.ijbiomac.2013.12.007.", "ArticleIdList": ["10.1016/j.ijbiomac.2013.12.007", "24333230"]}, {"Citation": "Zhang L., Han Y.-J., Zhang X., Wang X., Bao B., Qu W., Liu J. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPK\u03b11 signalling in adipose tissue macrophages. Diabetologia. 2016;59:2219\u20132228. doi: 10.1007/s00125-016-4039-8.", "ArticleIdList": ["10.1007/s00125-016-4039-8", "27377644"]}, {"Citation": "Andrade N., Ara\u00fajo J.R., Correia-Branco A., Carletti J.V., Martel F. Effect of dietary polyphenols on fructose uptake by human intestinal epithelial (Caco-2) cells. J. Funct.Foods. 2017;36:429\u2013439. doi: 10.1016/j.jff.2017.07.032.", "ArticleIdList": ["10.1016/j.jff.2017.07.032"]}, {"Citation": "Mojica L., Berhow M., De Mejia E.G. Black bean coat anthocyanin-rich extracts and pure anthocyanins modulated molecular markers of diabetes. FASEB J. 2017;31:646. 38."}, {"Citation": "Rodriguez A.G., Karakayaa S. 2017. In Vitro \u03b1\u2013amylase Inhibition and \u03b1\u2013glucosidase Inhibition Activities of Biscuit Enriched with Anthocyanin and Docosahexaenoic Acid."}, {"Citation": "Xue B., Tian J., Wang Y., Jin B., Deng H., Gao N., Xie X., Tang S., Li B. Mechanism underlying the interaction of malvidin-3-O-galactoside with protein tyrosine phosphatase-1B and \u03b1-glucosidase. J. Mol. Struct. 2022;1253"}, {"Citation": "Ong K.C., Khoo H.-E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transporter translocation. Biochem. Pharmacol. 1996;51:423\u2013429.", "ArticleIdList": ["8619886"]}, {"Citation": "Ong K.C., Khoo H.-E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 2000;67:1695\u20131705. doi: 10.1016/S0024-3205(00)00758-X.", "ArticleIdList": ["10.1016/S0024-3205(00)00758-X", "11021354"]}, {"Citation": "Strobel P., Allard C., Perez-Acle T., Calderon R., Aldunate R., Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem. J. 2005;386:471\u2013478. doi: 10.1042/BJ20040703.", "ArticleIdList": ["10.1042/BJ20040703", "PMC1134865", "15469417"]}, {"Citation": "Ding Y., Dai X., Zhang Z., Li Y. Myricetin attenuates hyperinsulinemia-induced insulin resistance in skeletal muscle cells. Eur. Food Res. Technol. 2012;234:873\u2013881. doi: 10.1007/s00217-012-1701-3.", "ArticleIdList": ["10.1007/s00217-012-1701-3"]}, {"Citation": "Arumugam B., Palanisamy U.D., Chua K.H., Kuppusamy U.R. Potential antihyperglycaemic effect of myricetin derivatives from Syzygium malaccense. J. Funct.Foods. 2016;22:325\u2013336. doi: 10.1016/j.jff.2016.01.038.", "ArticleIdList": ["10.1016/j.jff.2016.01.038"]}, {"Citation": "Meng Y., Su A., Yuan S., Zhao H., Tan S., Hu C., Deng H., Guo Y. Evaluation of total flavonoids, myricetin, and quercetin from hovenia dulcis thunb. As inhibitors of \u03b1-amylase and \u03b1-glucosidase. Plant Foods Hum. Nutr. 2016;71:444\u2013449. doi: 10.1007/s11130-016-0581-2.", "ArticleIdList": ["10.1007/s11130-016-0581-2", "27787697"]}, {"Citation": "Li Y.-X., Cheng K.-C., Liu I.-M., Niu H.-S. Myricetin increases circulating adropin level after activation of glucagon-like peptide 1 (GLP-1) receptor in type-1 diabetic rats. Pharmaceuticals. 2022;15:173.", "ArticleIdList": ["PMC8877079", "35215286"]}, {"Citation": "Yang L., Gao Y., Gong J., Wang H., Farag M.A., Simal-Gandara J., Zhao Y., Nie S., Xiao J. Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction. Food Front. 2022;3:749\u2013772."}, {"Citation": "Lim S., Soh K., Kuppusamy U. Effects of naringenin on lipogenesis, lipolysis and glucose uptake in rat adipocyte primary culture: a natural antidiabetic agent. Internet J. Alternative Med. 2008;5:11. 11."}, {"Citation": "Ortiz-Andrade R.R., S\u00e1nchez-Salgado J.C., Navarrete-V\u00e1zquez G., Webster S.P., Binnie M., Garc\u00eda-Jim\u00e9nez S., Le\u00f3n-Rivera I., Cigarroa-V\u00e1zquez P., Villalobos-Molina R., Estrada-Soto S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab. 2008;10:1097\u20131104. doi: 10.1111/j.1463-1326.2008.00869.x.", "ArticleIdList": ["10.1111/j.1463-1326.2008.00869.x", "18355329"]}, {"Citation": "Zygmunt K., Faubert B., MacNeil J., Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem. Biophys. Res. Commun. 2010;398:178\u2013183. doi: 10.1016/j.bbrc.2010.06.048.", "ArticleIdList": ["10.1016/j.bbrc.2010.06.048", "20558145"]}, {"Citation": "Bhattacharya S., Oksbjerg N., Young J.F., Jeppesen P.B. Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes. Metab. 2014;16:602\u2013612. doi: 10.1111/dom.12236.", "ArticleIdList": ["10.1111/dom.12236", "24205999"]}, {"Citation": "Bhattacharya S., Rasmussen M.K., Christensen L.P., Young J.F., Kristiansen K., Oksbjerg N. Naringenin and falcarinol stimulate glucose uptake and TBC1D1 phosphorylation in porcine myotube cultures. J. Biochem. Pharmacol. Res. 2014;2:91\u201398."}, {"Citation": "Priscilla D.H., Roy D., Suresh A., Kumar V., Thirumurugan K. Naringenin inhibits \u03b1-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem. Biol. Interact. 2014;210:77\u201385. doi: 10.1016/j.cbi.2013.12.014.", "ArticleIdList": ["10.1016/j.cbi.2013.12.014", "24412302"]}, {"Citation": "Singh A.K., Raj V., Keshari A.K., Rai A., Kumar P., Rawat A., Maity B., Kumar D., Prakash A., De A., Samanta A., Bhattacharya B., Saha S. Isolated mangiferin and naringenin exert antidiabetic effect via PPAR \u03b3/GLUT4 dual agonistic action with strong metabolic regulation. Chem. Biol. Interact. 2018;280:33\u201344. doi: 10.1016/j.cbi.2017.12.007.", "ArticleIdList": ["10.1016/j.cbi.2017.12.007", "29223569"]}, {"Citation": "Prasad B.S., Srinivasan K.K. Nat. Prod. Exp. Drug Discov. Springer; 2023. \u03b1-Glucosidase inhibition and upregulation of PPAR\u03b3 by flavonoid naringenin from Tinospora sinensis stem, a possible mechanism of antidiabetic activity; pp. 267\u2013289."}, {"Citation": "Dhanya R., Arun K.B., Nisha V.M., Syama H.P., Nisha P., Santhosh Kumar T.R., Jayamurthy P. Preconditioning L6 muscle cells with naringin ameliorates oxidative stress and increases glucose uptake. PLoS One. 2015;10 doi: 10.1371/journal.pone.0132429.", "ArticleIdList": ["10.1371/journal.pone.0132429", "PMC4492986", "26147673"]}, {"Citation": "Nzuza S., Ndwandwe D.E., Owira P.M.O. Naringin protects against HIV-1 protease inhibitors-induced pancreatic \u03b2-cell dysfunction and apoptosis. Mol. Cell. Endocrinol. 2016;437:1\u201310. doi: 10.1016/j.mce.2016.07.041.", "ArticleIdList": ["10.1016/j.mce.2016.07.041", "27496642"]}, {"Citation": "Dayarathne L.A., Ranaweera S.S., Natraj P., Rajan P., Lee Y.J., Han C.-H. The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells. J. Vet. Sci. 2021;22", "ArticleIdList": ["PMC8636664", "34854271"]}, {"Citation": "Li Y.Q., Zhou F.C., Gao F., Bian J.S., Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of \u03b1-glucosidase. J. Agric. Food Chem. 2009;57:11463\u201311468. doi: 10.1021/jf903083h.", "ArticleIdList": ["10.1021/jf903083h", "19938837"]}, {"Citation": "Eid H.M., Martineau L.C., Saleem A., Muhammad A., Vallerand D., Benhaddou-Andaloussi A., Nistor L., Afshar A., Arnason J.T., Haddad P.S. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol. Nutr. Food Res. 2010;54:991\u20131003. doi: 10.1002/mnfr.200900218.", "ArticleIdList": ["10.1002/mnfr.200900218", "20087853"]}, {"Citation": "Torres-Piedra M., Ortiz-Andrade R., Villalobos-Molina R., Singh N., Medina-Franco J.L., Webster S.P., Binnie M., Navarrete-V\u00e1zquez G., Estrada-Soto S. A comparative study of flavonoid analogues on streptozotocin\u2013nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition. Eur. J. Med. Chem. 2010;45:2606\u20132612. doi: 10.1016/j.ejmech.2010.02.049.", "ArticleIdList": ["10.1016/j.ejmech.2010.02.049", "20346546"]}, {"Citation": "Wein S., Behm N., Petersen R.K., Kristiansen K., Wolffram S. Quercetin enhances adiponectin secretion by a PPAR-\u03b3 independent mechanism. Eur. J. Pharm. Sci. 2010;41:16\u201322. doi: 10.1016/j.ejps.2010.05.004.", "ArticleIdList": ["10.1016/j.ejps.2010.05.004", "20580672"]}, {"Citation": "Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., Richard S., Quignard J., Gross R., Petit P., Bataille D., Oiry C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic \u03b2-cells against oxidative damage via the ERK1/2 pathway: quercetin effects on pancreatic \u03b2-cells. Br. J. Pharmacol. 2010;161:799\u2013814. doi: 10.1111/j.1476-5381.2010.00910.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00910.x", "PMC2992896", "20860660"]}, {"Citation": "Dai X., Ding Y., Zhang Z., Cai X., Bao L., Li Y. Quercetin but not quercitrin ameliorates tumor necrosis factor-alpha-induced insulin resistance in C2C12 skeletal muscle cells. Biol. Pharm. Bull. 2013;36:788\u2013795. doi: 10.1248/bpb.b12-00947.", "ArticleIdList": ["10.1248/bpb.b12-00947", "23439570"]}, {"Citation": "Dhanya R., Arun K.B., Syama H.P., Nisha P., Sundaresan A., Santhosh Kumar T.R., Jayamurthy P. Rutin and quercetin enhance glucose uptake in L6 myotubes under oxidative stress induced by tertiary butyl hydrogen peroxide. Food Chem. 2014;158:546\u2013554. doi: 10.1016/j.foodchem.2014.02.151.", "ArticleIdList": ["10.1016/j.foodchem.2014.02.151", "24731381"]}, {"Citation": "Eid H., Nachar A., Thong F., Sweeney G., Haddad P. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Phcog. Mag. 2015;11:74. doi: 10.4103/0973-1296.149708.", "ArticleIdList": ["10.4103/0973-1296.149708", "PMC4329636", "25709214"]}, {"Citation": "Dhanya R., Arya A.D., Nisha P., Jayamurthy P. Quercetin, a lead compound against type 2 diabetes ameliorates glucose uptake via AMPK pathway in skeletal muscle cell line. Front. Pharmacol. 2017;8:336. doi: 10.3389/fphar.2017.00336.", "ArticleIdList": ["10.3389/fphar.2017.00336", "PMC5462925", "28642704"]}, {"Citation": "Wang J.-Y., Nie Y.-X., Dong B.-Z., Cai Z.-C., Zeng X.-K., Du L., Zhu X., Yin X.-X. Quercetin protects islet \u03b2-cells from oxidation-induced apoptosis via Sirt3 in T2DM, Iran. J. Basic Med. Sci. 2021;24:629.", "ArticleIdList": ["PMC8244598", "34249264"]}, {"Citation": "Qu X., Li J., Yan P., Wang G., Liu W., Zeng Y., Liu L. Quercetin of Potentilla bifurca 3-glycosylation substitution impact the inhibitory activity on \u03b1-glucosidase. Phcog. Mag. 2022;18:458."}, {"Citation": "Shen H., Wang J., Ao J., Hou Y., Xi M., Cai Y., Li M., Luo A. Structure-activity relationships and the underlying mechanism of \u03b1-amylase inhibition by hyperoside and quercetin: multi-spectroscopy and molecular docking analyses. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2023;285", "ArticleIdList": ["36115306"]}, {"Citation": "Dai X., Ding Y., Zhang Z., Cai X., Li Y. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F \u03b2-cells via the mitochondrial pathway and NF-\u03baB signaling. Int. J. Mol. Med. 2013;31:265\u2013271. doi: 10.3892/ijmm.2012.1177.", "ArticleIdList": ["10.3892/ijmm.2012.1177", "23138875"]}, {"Citation": "Zhang L., Zhang S.-T., Yin Y.-C., Xing S., Li W.-N., Fu X.-Q. Hypoglycemic effect and mechanism of isoquercitrin as an inhibitor of dipeptidyl peptidase-4 in type 2 diabetic mice. RSC Adv. 2018;8:14967\u201314974. doi: 10.1039/C8RA00675J.", "ArticleIdList": ["10.1039/C8RA00675J", "PMC9080018", "35541310"]}, {"Citation": "Kappel V.D., Cazarolli L.H., Pereira D.F., Postal B.G., Zamoner A., Reginatto F.H., Silva F.R.M.B. Involvement of GLUT-4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle: effect of rutin on glucose uptake. J. Pharm. Pharmacol. 2013;65:1179\u20131186. doi: 10.1111/jphp.12066.", "ArticleIdList": ["10.1111/jphp.12066", "23837585"]}, {"Citation": "Hsu C.-Y., Shih H.-Y., Chia Y.-C., Lee C.-H., Ashida H., Lai Y.-K., Weng C.-F. Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation. Mol. Nutr. Food Res. 2014;58:1168\u20131176. doi: 10.1002/mnfr.201300691.", "ArticleIdList": ["10.1002/mnfr.201300691", "24668568"]}, {"Citation": "Oboh G., Ademosun A.O., Ayeni P.O., Omojokun O.S., Bello F. Comparative effect of quercetin and rutin on \u03b1-amylase, \u03b1-glucosidase, and some pro-oxidant-induced lipid peroxidation in rat pancreas. Comp. Clin. Pathol. 2015;24:1103\u20131110. doi: 10.1007/s00580-014-2040-5.", "ArticleIdList": ["10.1007/s00580-014-2040-5"]}, {"Citation": "Lee D.-G., Jang I.S., Yang K.E., Yoon S.-J., Baek S., Lee J.Y., Suzuki T., Chung K.-Y., Woo S.-H., Choi J.-S. Effect of rutin from tartary buckwheat sprout on serum glucose-lowering in animal model of type 2 diabetes. Acta Pharm. 2016;66:297\u2013302. doi: 10.1515/acph-2016-0021.", "ArticleIdList": ["10.1515/acph-2016-0021", "27279072"]}, {"Citation": "Aitken J.F., Loomes K.M., Riba-Garcia I., Unwin R.D., Prijic G., Phillips A.S., Phillips A.R.J., Wu D., Poppitt S.D., Ding K., Barran P.E., Dowsey A.W., Cooper G.J.S. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro , and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. Biochem. Biophys. Res. Commun. 2017;482:625\u2013631. doi: 10.1016/j.bbrc.2016.11.083.", "ArticleIdList": ["10.1016/j.bbrc.2016.11.083", "27865831"]}, {"Citation": "Guo Yuchen.  Degree Thesis of Institute of Biotechnology. ZTE University; 2019. Strictinin isolated from Raw Pu-erh tea, a potent aphla-glucosidase inhibitor, reduces postprandial blood glucose in C57BL/6J mice.https://www.airitilibrary.com/Publication/alDetailedMesh?docid=U0005-1607201918071000"}, {"Citation": "Vellingiri V., Ganesh S., Venkat M., Pemaiah B. Docking studies on antidiabetic molecular targets of phytochemical compounds of syzygium cumini (l.) Skeels. Asian J. Pharm. Clin. Res. 2016;9:287. doi: 10.22159/ajpcr.2016.v9s3.14920.", "ArticleIdList": ["10.22159/ajpcr.2016.v9s3.14920"]}, {"Citation": "Cazarolli L.H., Kappel V.D., Pereira D.F., Moresco H.H., Brighente I.M.C., Pizzolatti M.G., Silva F.R.M.B. Anti-hyperglycemic action of apigenin-6-C-\u03b2-fucopyranoside from Averrhoa carambola. Fitoterapia. 2012;83:1176\u20131183. doi: 10.1016/j.fitote.2012.07.003.", "ArticleIdList": ["10.1016/j.fitote.2012.07.003", "22796400"]}, {"Citation": "Cazarolli L.H., Folador P., Moresco H.H., Brighente I.M.C., Pizzolatti M.G., Silva F.R.M.B. Mechanism of action of the stimulatory effect of apigenin-6-C-(2\u2033-O-\u03b1-l-rhamnopyranosyl)-\u03b2-l-fucopyranoside on 14C-glucose uptake. Chem. Biol. Interact. 2009;179:407\u2013412. doi: 10.1016/j.cbi.2008.11.012.", "ArticleIdList": ["10.1016/j.cbi.2008.11.012", "19070612"]}, {"Citation": "Cazarolli L.H., Folador P., Moresco H.H., Brighente I.M.C., Pizzolatti M.G., Silva F.R.M.B. Stimulatory effect of apigenin-6-C-\u03b2-l-fucopyranoside on insulin secretion and glycogen synthesis. Eur. J. Med. Chem. 2009;44:4668\u20134673. doi: 10.1016/j.ejmech.2009.07.001.", "ArticleIdList": ["10.1016/j.ejmech.2009.07.001", "19625113"]}, {"Citation": "Panda S., Kar A. Apigenin (4\u2018,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J. Pharm. Pharmacol. 2007;59:1543\u20131548. doi: 10.1211/jpp.59.11.0012.", "ArticleIdList": ["10.1211/jpp.59.11.0012", "17976266"]}, {"Citation": "Esmaeili M.A., Sadeghi H. Pancreatic \u0392-cell protective effect of rutin and apigenin isolated from Teucrium polium. Pharmacol. Online. 2009;2:341\u2013353."}, {"Citation": "Hossain C.M., Ghosh M.K., Satapathy B.S., Dey N.S., Mukherjee B. Apigenin causes biochemical modulation, GLUT4 and Cd38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am. J. Pharmacol. Toxicol. 2014;9:39\u201352."}, {"Citation": "Jung U., Cho Y.-Y., Choi M.-S. Apigenin ameliorates dyslipidemia, hepatic steatosis and insulin resistance by modulating metabolic and transcriptional profiles in the liver of high-fat diet-induced obese mice. Nutrients. 2016;8:305. doi: 10.3390/nu8050305.", "ArticleIdList": ["10.3390/nu8050305", "PMC4882717", "27213439"]}, {"Citation": "Ren B., Qin W., Wu F., Wang S., Pan C., Wang L., Zeng B., Ma S., Liang J. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur. J. Pharmacol. 2016;773:13\u201323. doi: 10.1016/j.ejphar.2016.01.002.", "ArticleIdList": ["10.1016/j.ejphar.2016.01.002", "26801071"]}, {"Citation": "Wang N., Yi W.J., Tan L., Zhang J.H., Xu J., Chen Y., Qin M., Yu S., Guan J., Zhang R. Apigenin attenuates streptozotocin-induced pancreatic \u03b2 cell damage by its protective effects on cellular antioxidant defense. In Vitro Cell. Dev. Biol. Anim. 2017;53:554\u2013563. doi: 10.1007/s11626-017-0135-4.", "ArticleIdList": ["10.1007/s11626-017-0135-4", "28181104"]}, {"Citation": "Anandan S., Urooj A. Hypoglycemic effects of apigenin from morus indica in streptozotocin induced diabetic rats. Int J Cur Res Rev. 2021;13:100."}, {"Citation": "Michel F.Y. Arbutin diabetes. Exp. Biol. Med. 1936;35:62\u201364. doi: 10.3181/00379727-35-8858P.", "ArticleIdList": ["10.3181/00379727-35-8858P"]}, {"Citation": "Azarbayjani M.A., Shirkhani S., Pouramir M. The effect of a swim workout program along with the use of arbutin on glucose and insulin levels in rats with hyperglycemia. Int. J. Biosci. 2014;IJB 4:292\u2013297."}, {"Citation": "Farzanegi P. The effects of aerobic training and arbutin on GLP1 and GLP1R in diabetes Rats. Indian J Fundam Appl Life Sci. 2014;4:2231\u20136345."}, {"Citation": "Li H., Cao W., Wei L.-F., Xia J.-Q., Gu Y., Gu L.-M., Pan C.-Y., Liu Y.-Q., Tian Y.-Z., Lu M. Arbutin alleviates diabetic symptoms by attenuating oxidative stress in a mouse model of type 1 diabetes. Int. J. Diabetes Dev. Ctries. 2021;41:586\u2013592."}, {"Citation": "Matsumoto N., Ishigaki F., Ishigaki A., Iwashina H., Hara Y. Reduction of blood glucose levels by tea catechin. Biosci. Biotechnol. Biochem. 1993;57:525\u2013527. doi: 10.1271/bbb.57.525.", "ArticleIdList": ["10.1271/bbb.57.525"]}, {"Citation": "Igarashi K., Honma K., Yoshinari O., Nanjo F., Hara Y. Effects of dietary catechins on glucose tolerance, blood pressure and oxidative status in goto-kakizaki rats. J. Nutr. Sci. Vitaminol. 2007;53:496\u2013500. doi: 10.3177/jnsv.53.496.", "ArticleIdList": ["10.3177/jnsv.53.496", "18202537"]}, {"Citation": "Park J., Jin J., Baek W., Park S., Sung H., Kim Y., Lee J., Song D. Ambivalent role of gallated catechins in glucose tolerance in humans: a novel insight into non-absorbable gallated catechin-derived inhibitors of glucose absorption. J. Physiol. Pharmacol. 2009;60:101\u2013109.", "ArticleIdList": ["20065503"]}, {"Citation": "Daisy P., Balasubramanian K., Rajalakshmi M., Eliza J., Selvaraj J. Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine. 2010;17:28\u201336. doi: 10.1016/j.phymed.2009.10.018.", "ArticleIdList": ["10.1016/j.phymed.2009.10.018", "19931438"]}, {"Citation": "Huang C.F., Chen Y.W., Yang C.Y., Lin H.Y., Way T.D., Chiang W., Liu S.H. Extract of Lotus leaf (Nelumbo nucifera) and its active constituent catechin with insulin secretagogue activity. J. Agric. Food Chem. 2011;59:1087\u20131094. doi: 10.1021/jf103382h.", "ArticleIdList": ["10.1021/jf103382h", "21235242"]}, {"Citation": "Imada S., Tanaka A., Nishiumi S., Ashida H. Concentration of catechins and caffeine in black tea affects suppression of fat accumulation and hyperglycemia in high-fat diet-fed mice. Food Sci. Technol. Res. 2011;17:353\u2013359. doi: 10.3136/fstr.17.353.", "ArticleIdList": ["10.3136/fstr.17.353"]}, {"Citation": "Pitchai D., Manikkam R. Hypoglycemic and insulin mimetic impact of catechin isolated from Cassia fistula: a substantiate in silico approach through docking analysis. Med. Chem. Res. 2012;21:2238\u20132250. doi: 10.1007/s00044-011-9722-1.", "ArticleIdList": ["10.1007/s00044-011-9722-1"]}, {"Citation": "Samarghandian S., Azimi-Nezhad M., Farkhondeh T. Catechin treatment ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Dose Response. 2017;15 doi: 10.1177/1559325817691158.", "ArticleIdList": ["10.1177/1559325817691158", "PMC5305023", "28228702"]}, {"Citation": "Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Nutrient-gene interactions-dietary cyanidin 3-ObD-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr. 2003;133:2125\u20132130.", "ArticleIdList": ["12840166"]}, {"Citation": "Sasaki R., Nishimura N., Hoshino H., Isa Y., Kadowaki M., Ichi T., Tanaka A., Nishiumi S., Fukuda I., Ashida H., Horio F., Tsuda T. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol. 2007;74:1619\u20131627. doi: 10.1016/j.bcp.2007.08.008.", "ArticleIdList": ["10.1016/j.bcp.2007.08.008", "17869225"]}, {"Citation": "Gharib A., Faezizadeh Z., Godarzee M. Treatment of diabetes in the mouse model by delphinidin and cyanidin hydrochloride in free and liposomal forms. Planta Med. 2013;79:1599\u20131604. doi: 10.1055/s-0033-1350908.", "ArticleIdList": ["10.1055/s-0033-1350908", "24108435"]}, {"Citation": "Daveri E., Cremonini E., Mastaloudis A., Hester S.N., Wood S.M., Waterhouse A.L., Anderson M., Fraga C.G., Oteiza P.I. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biol. 2018;18:16\u201324. doi: 10.1016/j.redox.2018.05.012.", "ArticleIdList": ["10.1016/j.redox.2018.05.012", "PMC6035912", "29890336"]}, {"Citation": "Grace M.H., Ribnicky D.M., Kuhn P., Poulev A., Logendra S., Yousef G.G., Raskin I., Lila M.A. Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton. Phytomedicine. 2009;16:406\u2013415. doi: 10.1016/j.phymed.2009.02.018.", "ArticleIdList": ["10.1016/j.phymed.2009.02.018", "PMC2718544", "19303751"]}, {"Citation": "Chakravarthy B., Gupta S., Gambhir S., Gode K. The prophylactic action of (-)-epicatechin against alloxan induced diabetes in rats. Life Sci. 1981;29:2043\u20132047.", "ArticleIdList": ["7031399"]}, {"Citation": "Chakravarthy B.K., Gupta S., Gode K.D. Functional beta cell regeneration in the islets of pancreas in alloxan induced diabetic rats by (\u2212)-epicatechin. Life Sci. 1982;31:2693\u20132697. doi: 10.1016/0024-3205(82)90713-5.", "ArticleIdList": ["10.1016/0024-3205(82)90713-5", "6759833"]}, {"Citation": "Sheehan E.W., Stiff D.D., Duah F., Slatkin D.J., Schiff P.L., Zemaitis M.A. The lack of effectiveness of (\u2212)-epicatechin against alloxan induced diabetes in Wistar rats. Life Sci. 1983;33:593\u2013597. doi: 10.1016/0024-3205(83)90246-1.", "ArticleIdList": ["10.1016/0024-3205(83)90246-1", "6877034"]}, {"Citation": "bone A.J., Hii C.S.T., Brown D., Smith W., Howell S.L. Assessment of the antidiabetic activity of epicatechin in streptozotocin-diabetic and spontaneously diabetic BB/E rats. Biosci. Rep. 1985;5:215\u2013221. doi: 10.1007/BF01119590.", "ArticleIdList": ["10.1007/BF01119590", "4016223"]}, {"Citation": "Bettaieb A., Vazquez Prieto M.A., Rodriguez Lanzi C., Miatello R.M., Haj F.G., Fraga C.G., Oteiza P.I. (\u2212)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 2014;72:247\u2013256. doi: 10.1016/j.freeradbiomed.2014.04.011.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.04.011", "PMC4077617", "24746618"]}, {"Citation": "Shih C.-C., Wu J.-B., Jian J.-Y., Lin C.-H., Ho H.-Y. (\u2212)-Epicatechin-3-O-\u03b2-d-allopyranoside from Davallia formosana, prevents diabetes and hyperlipidemia by regulation of glucose transporter 4 and AMP-activated protein kinase phosphorylation in high-fat-fed mice. Int. J. Mol. Sci. 2015;16:24983\u201325001. doi: 10.3390/ijms161024983.", "ArticleIdList": ["10.3390/ijms161024983", "PMC4632785", "26492243"]}, {"Citation": "Cremonini E., Bettaieb A., Haj F.G., Fraga C.G., Oteiza P.I. (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch. Biochem. Biophys. 2016;599:13\u201321. doi: 10.1016/j.abb.2016.03.006.", "ArticleIdList": ["10.1016/j.abb.2016.03.006", "PMC5523407", "26968772"]}, {"Citation": "Ibrahim G., Ahmed O., Abbas N., El Fateh M. Evaluation of the anti-diabetic effects of epicatechin and/or gallic acid in STZ/NA- induced diabetic Wister rats. Res. J. Appl. Biotechnol. 2018;4:87\u2013104. doi: 10.21608/rjab.2018.57527.", "ArticleIdList": ["10.21608/rjab.2018.57527"]}, {"Citation": "Akiyama S., Katsumata S., Suzuki K., Nakaya Y., Ishimi Y., Uehara M. Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in goto-kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 2009;73:2779\u20132782. doi: 10.1271/bbb.90576.", "ArticleIdList": ["10.1271/bbb.90576", "19966469"]}, {"Citation": "Revathy J., Abdullah S.S. Influence of hesperetin on glycoprotein components in diabetic rats. Int. J. Sci. Eng. Res. 2016;7:214\u2013220."}, {"Citation": "Revathy J. The role of hesperetin in the management of diabetes mellitus and its complications. J. Cancer Treat. Res. 2017;5:1. doi: 10.11648/j.jctr.20170501.11.", "ArticleIdList": ["10.11648/j.jctr.20170501.11"]}, {"Citation": "Revathy J., Subramani S., Sheik Abdullah S.H., Udaiyar M. Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats. Biomed. Pharmacother. 2018;97:98\u2013106. doi: 10.1016/j.biopha.2017.10.102.", "ArticleIdList": ["10.1016/j.biopha.2017.10.102", "29080465"]}, {"Citation": "Nerdy N., Meliala L., Barus B.R., Lestari P., Ginting S., Ariani P., Mierza V., Bakri T.K. Effect of hesperetin treatment on blood glucose level, spermatozoa quality, and spermatozoa quantity in alloxan-induced diabetic mice. J. Kedokt. Hewan-Indones. J. Vet. Sci. 2021;15:1\u20136."}, {"Citation": "Abdou H.M., Hamaad F.A., Ali E.Y., Ghoneum M.H. Antidiabetic efficacy of Trifolium alexandrinum extracts hesperetin and quercetin in ameliorating carbohydrate metabolism and activating IR and AMPK signaling in the pancreatic tissues of diabetic rats. Biomed. Pharmacother. 2022;149", "ArticleIdList": ["35344738"]}, {"Citation": "Jung U.J., Lee M.-K., Jeong K.-S., Choi M.-S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 2004;134:2499\u20132503.", "ArticleIdList": ["15465737"]}, {"Citation": "Toumi M.L., Merzoug S., Boutefnouchet A., Tahraoui A., Ouali K., Guellati M.A. Hesperidin, a natural citrus flavanone, alleviates hyperglycaemic state and attenuates embryopathies in pregnant diabetic mice. J. Med. Plants Res. 2009;3:862\u2013869."}, {"Citation": "Akiyama S., Katsumata S., Suzuki K., Ishimi Y., Wu J., Uehara M. Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 2009;46:87\u201392.", "ArticleIdList": ["PMC2803138", "20104270"]}, {"Citation": "Abdel-Moneim A., Ashour M., Mahmoud A., Ahmed O. Insulin sensitizing effects of hesperidin and naringin in experimental model of induced type 2 diabetes in rats: focus on tumor necrosis factor-alpha and resistin. Nat. Sci. 2011;7:134\u2013141."}, {"Citation": "Ahmed O.M., Mahmoud A.M., Abdel-Moneim A., Ashour M.B. Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats. Diabetol. Croat. 2012;41", "ArticleIdList": ["22809898"]}, {"Citation": "Dokumacioglu E., Iskender H., Sen T.M., Ince I., Dokumacioglu A., Kanbay Y., Erbas E., Saral S. The effects of hesperidin and quercetin on serum tumor necrosis factor-alpha and interleukin-6 levels in streptozotocin-induced diabetes model. Phcog. Mag. 2018;14:167.", "ArticleIdList": ["PMC5909310", "29720826"]}, {"Citation": "Sundaram R., Nandhakumar E., Haseena Banu H. Hesperidin, a citrus flavonoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Toxicol. Mech. Methods. 2019;29:644\u2013653. doi: 10.1080/15376516.2019.1646370.", "ArticleIdList": ["10.1080/15376516.2019.1646370", "31345080"]}, {"Citation": "Yoshida H., Tsuhako R., Sugita C., Kurokawa M. Glucosyl hesperidin has an anti-diabetic effect in high-fat diet-induced obese mice. Biol. Pharm. Bull. 2021;44:422\u2013430.", "ArticleIdList": ["33642550"]}, {"Citation": "Peng P., Jin J., Zou G., Sui Y., Han Y., Zhao D., Liu L. Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway. Exp. Ther. Med. 2021;21:1. 1.", "ArticleIdList": ["PMC7706385", "33273981"]}, {"Citation": "El-Shahawy A.A., Abdel-Moneim A., Ebeid A.S., Eldin Z.E., Zanaty M.I. A novel layered double hydroxide-hesperidin nanoparticles exert antidiabetic, antioxidant and anti-inflammatory effects in rats with diabetes. Mol. Biol. Rep. 2021;48:5217\u20135232.", "ArticleIdList": ["34244888"]}, {"Citation": "de Sousa E., Zanatta L., Seifriz I., Creczynski-Pasa T.B., Pizzolatti M.G., Szpoganicz B., Silva F.R.M.B. Hypoglycemic effect and antioxidant potential of kaempferol-3,7- O -(\u03b1)-dirhamnoside from bauhiniaforficata leaves. J. Nat. Prod. 2004;67:829\u2013832. doi: 10.1021/np030513u.", "ArticleIdList": ["10.1021/np030513u", "15165145"]}, {"Citation": "Zanatta L., Rosso \u00c2., Folador P., Figueiredo M.S., Pizzolatti M.G., Leite L.D., Silva F.R. Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle. J. Nat. Prod. 2008;71:532\u2013535.", "ArticleIdList": ["18303854"]}, {"Citation": "Cazarolli L.H., Folador P., Pizzolatti M.G., Mena Barreto Silva F.R. Signaling pathways of kaempferol-3-neohesperidoside in glycogen synthesis in rat soleus muscle. Biochimie. 2009;91:843\u2013849. doi: 10.1016/j.biochi.2009.04.004.", "ArticleIdList": ["10.1016/j.biochi.2009.04.004", "19376191"]}, {"Citation": "Rodr\u00edguez P., Gonz\u00e1lez-Mujica F., Berm\u00fadez J., Hasegawa M. Inhibition of glucose intestinal absorption by kaempferol 3-O-\u03b1-rhamnoside purified from Bauhinia megalandra leaves. Fitoterapia. 2010;81:1220\u20131223. doi: 10.1016/j.fitote.2010.08.007.", "ArticleIdList": ["10.1016/j.fitote.2010.08.007", "20727952"]}, {"Citation": "Zang Y., Sato H., Igarashi K. Anti-diabetic effects of a kaempferol glycoside-rich fraction from unripe soybean (edamame, Glycine max L. Merrill. \u2018Jindai\u2019) leaves on KK- Ay mice. Biosci. Biotechnol. Biochem. 2011;75:1677\u20131684. doi: 10.1271/bbb.110168.", "ArticleIdList": ["10.1271/bbb.110168", "21897048"]}, {"Citation": "Liu G., Liu Y., Sun C., Bao H., Yu J. Effects of kaempferol on glycolipid metabolism and insulin resistance in rats with type 2 diabetes. J. Clin. Med. Pract. 2012;9 http://en.cnki.com.cn/Article_en/CJFDTotal-XYZL201209002.htm"}, {"Citation": "Alkhalidy H., Moore W., Zhang Y., McMillan R., Wang A., Ali M., Suh K.-S., Zhen W., Cheng Z., Jia Z., Hulver M., Liu D. Small molecule kaempferol promotes insulin sensitivity and preserved pancreatic \u03b2 -cell mass in middle-aged obese diabetic mice. J. Diabetes Res. 2015;2015:1\u201314. doi: 10.1155/2015/532984.", "ArticleIdList": ["10.1155/2015/532984", "PMC4439495", "26064984"]}, {"Citation": "Luo C., Yang H., Tang C., Yao G., Kong L., He H., Zhou Y. Kaempferol alleviates insulin resistance via hepatic IKK/NF-\u03baB signal in type 2 diabetic rats. Int. Immunopharmacol. 2015;28:744\u2013750. doi: 10.1016/j.intimp.2015.07.018.", "ArticleIdList": ["10.1016/j.intimp.2015.07.018", "26263168"]}, {"Citation": "Zang Y., Zhang L., Igarashi K., Yu C. The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Funct. 2015;6:834\u2013841. doi: 10.1039/C4FO00844H.", "ArticleIdList": ["10.1039/C4FO00844H", "25599885"]}, {"Citation": "Alkhalidy H., Moore W., Wang Y., Luo J., McMillan R., Zhen W., Zhou K., Liu D. The flavonoid kaempferol ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production. Molecules. 2018;23:2338. doi: 10.3390/molecules23092338.", "ArticleIdList": ["10.3390/molecules23092338", "PMC6192519", "30216981"]}, {"Citation": "Alkhalidy H., Moore W., Wang A., Luo J., McMillan R.P., Wang Y., Zhen W., Hulver M.W., Liu D. Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice. J. Nutr. Biochem. 2018;58:90\u2013101. doi: 10.1016/j.jnutbio.2018.04.014.", "ArticleIdList": ["10.1016/j.jnutbio.2018.04.014", "PMC6095729", "29886193"]}, {"Citation": "Alshehri A.S., El-Kott A.F., Eleawa S.M., El-Gerbed M.S.A., Khalifa H.S., El-Kenawy A.E., Albadrani G.M., Abdel-Daim M.M. Kaempferol protects against streptozotocin-induced diabetic cardiomyopathy in rats by a hypoglycemic effect and upregulating SIRT1. J. Physiol. Pharmacol. 2021;72", "ArticleIdList": ["34810287"]}, {"Citation": "Al-Abbasi F.A., Kazmi I. 2022. Therapeutic Role of Kaempferol and Myricetin in Streptozotocin Induced Diabetes Synergistically via Modulation in Pancreatic Amylase, Glycogen Storage and Insulin Secretion.", "ArticleIdList": ["36583792"]}, {"Citation": "Zarzuelo A., Jimenez I., Gamez M., Utrilla P., Fernadez I., Torres M., Osuna I. Effects of luteolin 5-O-\u03b2-rutinoside in streptozotocin-induced diabetic rats. Life Sci. 1996;58:2311\u20132316.", "ArticleIdList": ["8649220"]}, {"Citation": "Zang Y., Igarashi K., Li Y. Anti-diabetic effects of luteolin and luteolin-7-O-glucoside on KK-Ay mice. Biosci. Biotechnol. Biochem. 2016;80:1580\u20131586. doi: 10.1080/09168451.2015.1116928.", "ArticleIdList": ["10.1080/09168451.2015.1116928", "27170065"]}, {"Citation": "Ge X., He X., Lin Z., Zhu Y., Jiang X., Zhao L., Zeng F., Chen L., Xu W., Liu T. 6, 8-(1, 3-Diaminoguanidine) luteolin and its Cr complex show hypoglycemic activities and alter intestinal microbiota composition in type 2 diabetes mice. Food Funct. 2022;13:3572\u20133589.", "ArticleIdList": ["35262159"]}, {"Citation": "Ge X., He X., Liu J., Zeng F., Chen L., Xu W., Shao R., Huang Y., Farag M.A., Capanoglu E. Amelioration of type 2 diabetes by the novel 6, 8-guanidyl luteolin quinone-chromium coordination via biochemical mechanisms and gut microbiota interaction. J. Adv. Res. 2022;46:173\u2013188.", "ArticleIdList": ["PMC10105086", "35700921"]}, {"Citation": "Guti\u00e9rrez R.M.P., G\u00f3mez J.T., Urby R.B., Soto J.G.C., Parra H.R. Evaluation of diabetes effects of selenium nanoparticles synthesized from a mixture of luteolin and diosmin on streptozotocin-induced type 2 diabetes in mice. Molecules. 2022;27:5642.", "ArticleIdList": ["PMC9457892", "36080407"]}, {"Citation": "Zou W., Zhang C., Gu X., Li X., Zhu H. Metformin in combination with malvidin prevents progression of non-alcoholic fatty liver disease via improving lipid and glucose metabolisms, and inhibiting inflammation in type 2 diabetes rats. Drug Des. Devel. Ther. 2021;15:2565.", "ArticleIdList": ["PMC8218939", "34168429"]}, {"Citation": "Liu I.-M., Liou S.-S., Lan T.-W., Hsu F.-L., Cheng J.-T. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2005;71:617\u2013621. doi: 10.1055/s-2005-871266.", "ArticleIdList": ["10.1055/s-2005-871266", "16041646"]}, {"Citation": "Liu I.-M., Liou S.-S., Cheng J.-T. Mediation of \u03b2-endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2006;104:199\u2013206. doi: 10.1016/j.jep.2005.09.001.", "ArticleIdList": ["10.1016/j.jep.2005.09.001", "16203117"]}, {"Citation": "Liu I.-M., Tzeng T.-F., Liou S.-S., Lan T.-W. Improvement of insulin sensitivity in obese zucker rats by myricetin extracted from Abelmoschus moschatus. Planta Med. 2007;73:1054\u20131060. doi: 10.1055/s-2007-981577.", "ArticleIdList": ["10.1055/s-2007-981577", "17694473"]}, {"Citation": "Liu I.-M., Tzeng T.-F., Liou S.-S., Lan T.-W. Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in rats. Life Sci. 2007;81:1479\u20131488. doi: 10.1016/j.lfs.2007.08.045.", "ArticleIdList": ["10.1016/j.lfs.2007.08.045", "17976658"]}, {"Citation": "Tzeng T.-F., Liou S.-S., Liu I.-M. Myricetin ameliorates Defective post-receptor insulin signaling via \u03b2-endorphin signaling in the skeletal muscles of fructose-fed rats. Evid. Based Complement. Alternat. Med. 2011;2011:1\u20139. doi: 10.1093/ecam/neq017.", "ArticleIdList": ["10.1093/ecam/neq017", "PMC3136182", "21785619"]}, {"Citation": "Kandasamy N., Ashokkumar N. Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium-induced experimental diabetic nephrotoxic rats. Biomed. Prev. Nutr. 2012;2:246\u2013251. doi: 10.1016/j.bionut.2012.04.003.", "ArticleIdList": ["10.1016/j.bionut.2012.04.003"]}, {"Citation": "Choi Ha-Neul, Kang M.-J., Lee S.-J., Kim J.-I. Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet. Nutr. Res. Pract. 2014;8:544. doi: 10.4162/nrp.2014.8.5.544.", "ArticleIdList": ["10.4162/nrp.2014.8.5.544", "PMC4198968", "25324935"]}, {"Citation": "Kandasamy N., Ashokkumar N. Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin\u2013cadmium induced diabetic nephrotoxic rats. Toxicol. Appl. Pharmacol. 2014;279:173\u2013185. doi: 10.1016/j.taap.2014.05.014.", "ArticleIdList": ["10.1016/j.taap.2014.05.014", "24923654"]}, {"Citation": "Kang S.-J., Park J.-H.Y., Choi H.-N., Kim J.-I. \u03b1-glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus. Food Sci. Biotechnol. 2015;24:1897\u20131900. doi: 10.1007/s10068-015-0249-y.", "ArticleIdList": ["10.1007/s10068-015-0249-y"]}, {"Citation": "Li Y., Zheng X., Yi X., Liu C., Kong D., Zhang J., Gong M. Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist. FASEB J. 2017;31:2603\u20132611. doi: 10.1096/fj.201601339R.", "ArticleIdList": ["10.1096/fj.201601339R", "PMC5434659", "28270518"]}, {"Citation": "Hu T., Yuan X., Wei G., Luo H., Lee H.J., Jin W. Myricetin-induced brown adipose tissue activation prevents obesity and insulin resistance in db/db mice. Eur. J. Nutr. 2018;57:391\u2013403. doi: 10.1007/s00394-017-1433-z.", "ArticleIdList": ["10.1007/s00394-017-1433-z", "28439667"]}, {"Citation": "Annadurai T., Muralidharan A.R., Joseph T., Hsu M.J., Thomas P.A., Geraldine P. Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin\u2013nicotinamide-induced experimental diabetic rats. J. Physiol. Biochem. 2012;68:307\u2013318. doi: 10.1007/s13105-011-0142-y.", "ArticleIdList": ["10.1007/s13105-011-0142-y", "22234849"]}, {"Citation": "Annadurai T., Thomas P.A., Geraldine P. Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin- nicotinamide-induced experimental diabetes mellitus. Free Radic. Res. 2013;47:793\u2013803. doi: 10.3109/10715762.2013.823643.", "ArticleIdList": ["10.3109/10715762.2013.823643", "23841752"]}, {"Citation": "Priscilla D.H., Jayakumar M., Thirumurugan K. Flavanone naringenin: an effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats. J. Funct.Foods. 2015;14:363\u2013373. doi: 10.1016/j.jff.2015.02.005.", "ArticleIdList": ["10.1016/j.jff.2015.02.005"]}, {"Citation": "Sharma A., Patar A.K., Bhan S. Cytoprotective, antihyperglycemic and antioxidative effect of naringenin on liver and kidneys of Swiss diabetic mice. Int. J. Health Sci. 2016;14"}, {"Citation": "Yoshida H., Tsuhako R., Atsumi T., Narumi K., Watanabe W., Sugita C., Kurokawa M. Naringenin interferes with the anti-diabetic actions of pioglitazone via pharmacodynamic interactions. J. Nat. Med. 2017;71:442\u2013448. doi: 10.1007/s11418-016-1063-4.", "ArticleIdList": ["10.1007/s11418-016-1063-4", "27915399"]}, {"Citation": "Ahmed O.M., Hassan M.A., Abdel-Twab S.M., Abdel Azeem M.N. Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats. Biomed. Pharmacother. 2017;94:197\u2013205. doi: 10.1016/j.biopha.2017.07.094.", "ArticleIdList": ["10.1016/j.biopha.2017.07.094", "28759757"]}, {"Citation": "Park S., Sim K.-S., Hwangbo Y., Park S.-J., Kim Y.-J., Kim J.-H. Naringenin and phytoestrogen 8-prenylnaringenin protect against islet dysfunction and inhibit apoptotic signaling in insulin-deficient diabetic mice. Molecules. 2022;27:4227.", "ArticleIdList": ["PMC9268740", "35807469"]}, {"Citation": "Punithavathi V.R., Anuthama R., Prince P.S.M. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. J. Appl. Toxicol. 2008;28:806\u2013813. doi: 10.1002/jat.1343.", "ArticleIdList": ["10.1002/jat.1343", "18344197"]}, {"Citation": "Pari L., Suman S. Efficacy of naringin on hepatic enzymes of carbohydrate metabolism in streptozotocin-nicotinamide induced type 2 diabetic rats. Int J Pharm Biol Arch. 2010;1:280\u2013286."}, {"Citation": "Kumar Sharma A., Bharti S., Ojha S., Bhatia J., Kumar N., Ray R., Kumari S., Singh Arya D. Up-regulation of PPAR\u03b3, heat shock protein-27 and -72 by naringin attenuates insulin resistance, \u03b2-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br. J. Nutr. 2011;106:1713\u20131723. doi: 10.1017/S000711451100225X.", "ArticleIdList": ["10.1017/S000711451100225X", "21736771"]}, {"Citation": "Xulu S., Oroma Owira P.M. Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes. J. Cardiovasc. Pharmacol. 2012;59:133\u2013141. doi: 10.1097/FJC.0b013e31823827a4.", "ArticleIdList": ["10.1097/FJC.0b013e31823827a4", "21964158"]}, {"Citation": "Al-Kurdy M.J.J. Hypoglycemic and hypolipidimic effect of naringin in diabetic male rats. Al-Qadisiyah J. Vet. Med. Sci. 2014;13:43. doi: 10.29079/vol13iss1art276.", "ArticleIdList": ["10.29079/vol13iss1art276"]}, {"Citation": "Pari L., Chandramohan R. Modulatory effects of naringin on hepatic key enzymes of carbohydrate metabolism in high-fat diet/low-dose streptozotocin-induced diabetes in rats. Gen. Physiol. Biophys. 2017;36:343\u2013352. doi: 10.4149/gpb_2016055.", "ArticleIdList": ["10.4149/gpb_2016055", "28635611"]}, {"Citation": "Lim Y.J., Kim J.H., Pan J.H., Kim J.K., Park T.-S., Kim Y.J., Lee J.H., Kim J.H. Naringin protects pancreatic \u03b2-cells against oxidative stress-induced apoptosis by inhibiting both intrinsic and extrinsic pathways in insulin-deficient diabetic mice. Mol. Nutr. Food Res. 2018;62 doi: 10.1002/mnfr.201700810.", "ArticleIdList": ["10.1002/mnfr.201700810", "29314619"]}, {"Citation": "Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 2003;135:357\u2013364. doi: 10.1016/S1532-0456(03)00140-6.", "ArticleIdList": ["10.1016/S1532-0456(03)00140-6", "12927910"]}, {"Citation": "Shetty A.K., Rashmi R., Rajan M.G.R., Sambaiah K., Salimath P.V. Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutr. Res. 2004;24:373\u2013381. doi: 10.1016/j.nutres.2003.11.010.", "ArticleIdList": ["10.1016/j.nutres.2003.11.010"]}, {"Citation": "Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and ?-cell damage in rat pancreas. Pharmacol. Res. 2005;51:117\u2013123. doi: 10.1016/j.phrs.2004.06.002.", "ArticleIdList": ["10.1016/j.phrs.2004.06.002", "15629256"]}, {"Citation": "Adewole S.O., Caxton-Martins E.A., Ojewole J.A. Protective effect of quercetin on the morphology of pancreatic \u03b2-cells of streptozotocin-treated diabetic rats, Afr. J. Tradit. Complement. Altern. Med. 2007;4:64\u201374.", "ArticleIdList": ["PMC2816429", "20162074"]}, {"Citation": "Panda S., Kar A. Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. Biofactors. 2007;31:201\u2013210. doi: 10.1002/biof.5520310307.", "ArticleIdList": ["10.1002/biof.5520310307", "18997283"]}, {"Citation": "Luka\u010d\u00ednov\u00e1 A., Moj\u017ei\u0161 J., Be\u0148a\u010dka R., Keller J., Maguth T., Kurila P., Va\u0161ko L., Racz O., Ni\u0161tiar F. others, Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats. Acta Vet. Brno. 2008;77:175\u2013182."}, {"Citation": "Kannappan S., Anuradha C.V. Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model. INDIAN J MED RES. 2009:9.", "ArticleIdList": ["19535835"]}, {"Citation": "Kobori M., Masumoto S., Akimoto Y., Takahashi Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 2009;53:859\u2013868. doi: 10.1002/mnfr.200800310.", "ArticleIdList": ["10.1002/mnfr.200800310", "19496084"]}, {"Citation": "Abdelmoaty M.A., Ibrahim M.A., Ahmed N.S., Abdelaziz M.A. Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J. Clin. Biochem. 2010;25:188\u2013192. doi: 10.1007/s12291-010-0034-x.", "ArticleIdList": ["10.1007/s12291-010-0034-x", "PMC3453107", "23105908"]}, {"Citation": "El-Baky A.E.A. Quercetin protective action on oxidative stress, sorbitol, insulin risistance and \u03b2-cells function in expermintal diabetic rats. Int J Pharm Stud Res. 2011:11\u201318."}, {"Citation": "Kim J.-H., Kang M.-J., Choi H.-N., Jeong S.-M., Lee Y.-M., Kim J.-I. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr. Res. Pract. 2011;5:107. doi: 10.4162/nrp.2011.5.2.107.", "ArticleIdList": ["10.4162/nrp.2011.5.2.107", "PMC3085798", "21556223"]}, {"Citation": "Hussain S.A., Ahmed Z.A., Mahwi T.O., Aziz T.A. Effect of quercetin on postprandial glucose excursion after mono- and disaccharides challenge in normal and diabetic rats. J. Diabetes Mellit. 2012;2:82\u201387. doi: 10.4236/jdm.2012.21013.", "ArticleIdList": ["10.4236/jdm.2012.21013"]}, {"Citation": "Jadhav R., Puchchakayala G. Hypoglycemic and antidiabetic activity of flavonoids: boswellic acid, ellagic acid, quercetin, rutin on streptozotocin-nicotinamide induced type 2 diabetic rats. Int. J. Pharm. Pharm. Sci. 2012;1"}, {"Citation": "Jeong S.-M., Kang M.-J., Choi H.-N., Kim J.-H., Kim J.-I. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr. Res. Pract. 2012;6:201. doi: 10.4162/nrp.2012.6.3.201.", "ArticleIdList": ["10.4162/nrp.2012.6.3.201", "PMC3395784", "22808343"]}, {"Citation": "Rifaai R.A., El-Tahawy N.F., Ali Saber E. Effect of quercetin on the Endocrine pancreas of the experimentally induced diabetes in male Albino rats: a histological and Immunohistochemical study. J. Diabetes Metab. 2012:3. doi: 10.4172/2155-6156.1000182.", "ArticleIdList": ["10.4172/2155-6156.1000182"]}, {"Citation": "Alam MdM., Meerza D., Naseem I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci. 2014;109:8\u201314. doi: 10.1016/j.lfs.2014.06.005.", "ArticleIdList": ["10.1016/j.lfs.2014.06.005", "24946265"]}, {"Citation": "Arias N., Macarulla M.T., Aguirre L., Mart\u00ednez-Casta\u00f1o M.G., Portillo M.P. Quercetin can reduce insulin resistance without decreasing adipose tissue and skeletal muscle fat accumulation. Genes Nutr. 2014;9:361. doi: 10.1007/s12263-013-0361-7.", "ArticleIdList": ["10.1007/s12263-013-0361-7", "PMC3896623", "24338341"]}, {"Citation": "Yang D.K., Kang H.-S. Anti-diabetic effect of Cotreatment with quercetin and resveratrol in streptozotocin-induced diabetic rats. Biomol. Ther. 2018;26:130\u2013138. doi: 10.4062/biomolther.2017.254.", "ArticleIdList": ["10.4062/biomolther.2017.254", "PMC5839491", "29462848"]}, {"Citation": "Oyedemi S.O., Nwaogu G., Chukwuma C.I., Adeyemi O.T., Matsabisa M.G., Swain S.S., Aiyegoro O.A. Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: in silico studies of molecular interaction of quercetin with hexokinase and catalase. J. Food Biochem. 2020;44 doi: 10.1111/jfbc.13127.", "ArticleIdList": ["10.1111/jfbc.13127", "31876980"]}, {"Citation": "H Bakr E.-S. Comparative study on antidiabetic effects of Coenzyme Q10 and quercetin on streptozotocin-induced hyperglycemia in rats. \u0645\u062c\u0644\u0629 \u0627\u0644\u0627\u0642\u062a\u0635\u0627\u062f \u0627\u0644\u0645\u0646\u0632\u0644\u064a. 2021;37:157\u2013176."}, {"Citation": "Liu H., Wang L., Li F., Jiang Y., Guan H., Wang D., Sun-Waterhouse D., Wu M., Li D. The synergistic protection of EGCG and quercetin against streptozotocin (STZ)-induced NIT-1 pancreatic \u03b2 cell damage via upregulation of BCL-2 expression by miR-16-5p. J. Nutr. Biochem. 2021;96", "ArticleIdList": ["34051305"]}, {"Citation": "Shaikhomar O.A., Bahattab O.S. Physiological effect of quercetin as a natural flavonoid to be used as hypoglycemic agent in diabetes mellitus type II rats. Saudi J Biomed Res. 2021;6:10\u201317."}, {"Citation": "Serra C.A., Dos Reis A.F., Calsa B., Bueno C.S., Helaehil J.V., de Souza S.A.R., de Oliveira C.A., Vanzella E.C., do Amaral M.E.C. Quercetin prevents insulin dysfunction in hypertensive animals. J. Diabetes Metab. Disord. 2022:1\u201311.", "ArticleIdList": ["PMC9167338", "35673430"]}, {"Citation": "Babujanarthanam R., Kavitha P., Pandian M.R. Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes: quercitrin improves glucose homeostasis in diabetic tissues. Fundam. Clin. Pharmacol. 2009;24:357\u2013364. doi: 10.1111/j.1472-8206.2009.00771.x.", "ArticleIdList": ["10.1111/j.1472-8206.2009.00771.x", "19689449"]}, {"Citation": "Babujanarthanam R., Kavitha P., Mahadeva Rao U.S., Pandian M.R. Quercitrin a bioflavonoid improves the antioxidant status in streptozotocin: induced diabetic rat tissues. Mol. Cell. Biochem. 2011;358:121\u2013129. doi: 10.1007/s11010-011-0927-x.", "ArticleIdList": ["10.1007/s11010-011-0927-x", "21713411"]}, {"Citation": "Babujanarthanam R., Kavitha P., Rajalakshmi G. Antihyperglycaemic and antioxidant role of quercitrin, a Bio- flavonoid, in streptozotocin-induced DiabeticWistar rat tissues. J. Pharm. Res. 2011:5."}, {"Citation": "Us M.R. Effects of quercitrin on diabetic Physiological criterions and hematological parameters studied in diabetic rats. Int. Med. J. 2019;26"}, {"Citation": "Paulo A., Martins S., Branco P., Dias T., Borges C., Rodrigues A.I., do C\u00e9u Costa M., Teixeira A., Mota-Filipe H. The opposing effects of the flavonoids isoquercitrin and Sissotrin, isolated fromPterospartum tridentatum, on oral glucose tolerance in rats. Phytother Res. 2008;22:539\u2013543. doi: 10.1002/ptr.2403.", "ArticleIdList": ["10.1002/ptr.2403", "18338765"]}, {"Citation": "Huang X.-L., He Y., Ji L.-L., Wang K.-Y., Wang Y.-L., Chen D.-F., Geng Y., OuYang P., Lai W.-M. Hepatoprotective potential of isoquercitrin against type 2 diabetes-induced hepatic injury in rats. Oncotarget. 2017;8 doi: 10.18632/oncotarget.21074.", "ArticleIdList": ["10.18632/oncotarget.21074", "PMC5731895", "29254185"]}, {"Citation": "Kamalakkannan N., Prince P.S.M. Antihyperglycaemic and antioxidant effect of rutin, a Polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin. Pharmacol. Toxicol. 2006;98:97\u2013103. doi: 10.1111/j.1742-7843.2006.pto_241.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_241.x", "16433898"]}, {"Citation": "Prince P.S.M., Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 2006;20:96\u2013102. doi: 10.1002/jbt.20117.", "ArticleIdList": ["10.1002/jbt.20117", "16615078"]}, {"Citation": "Hunyadi A., Martins A., Hsieh T.-J., Seres A., Zupk\u00f3 I. Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS One. 2012;7 doi: 10.1371/journal.pone.0050619.", "ArticleIdList": ["10.1371/journal.pone.0050619", "PMC3503931", "23185641"]}, {"Citation": "Niture N.T., Ansari A.A., Naik S.R. Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers. Indian J. Exp. Biol. 2014:8.", "ArticleIdList": ["25059040"]}, {"Citation": "Lee L.-C., Hou Y.-C., Hsieh Y.-Y., Chen Y.-H., Shen Y.-C., Lee I.-J., Shih M.-C.M., Hou W.-C., Liu H.-K. Dietary supplementation of rutin and rutin-rich buckwheat elevates endogenous glucagon-like peptide 1 levels to facilitate glycemic control in type 2 diabetic mice. J. Funct.Foods. 2021;85"}, {"Citation": "Rakhmat I.I., Yuslianti E.R., Koswara T. 12th Annu. Sci. Meet. Med. Fac. Univ. Jenderal Achmad Yani Int. Symp. Emerg. Prep. Disaster Response COVID 19 PandemicASMC 2021. Atlantis Press; 2021. Flavonoid-rutin effect to blood glucose level and pancreas regeneration in diabetic rats; pp. 64\u201366."}, {"Citation": "Amjadi S., Shahnaz F., Shokouhi B., Azarmi Y., Siahi-Shadbad M., Ghanbarzadeh S., Kouhsoltani M., Ebrahimi A., Hamishehkar H. Nanophytosomes for enhancement of rutin efficacy in oral administration for diabetes treatment in streptozotocin-induced diabetic rats. Int. J. Pharm. 2021;610", "ArticleIdList": ["34673162"]}, {"Citation": "Matsui T., Ebuchi S., Kobayashi M., Fukui K., Sugita K., Terahara N., Matsumoto K. Anti-hyperglycemic effect of Diacylated anthocyanin derived from Ipomoea batatas Cultivar Ayamurasaki can Be achieved through the r-glucosidase inhibitory action. J. Agric. Food Chem. 2002;50:7244\u20137248. doi: 10.1021/jf025913m.", "ArticleIdList": ["10.1021/jf025913m", "12452639"]}, {"Citation": "Osigwe C.C., Akah P.A., Nworu C.S., Okoye F.B. Apigenin: a methanol fraction component of Newbouldia laevis leaf, as a potential antidiabetic agent. J Phytopharm. 2017;6:38\u201344."}, {"Citation": "Su H.-C., Hung L.-M., Chen J.-K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2006;290:E1339\u2013E1346. doi: 10.1152/ajpendo.00487.2005.", "ArticleIdList": ["10.1152/ajpendo.00487.2005", "16434553"]}, {"Citation": "Chi T.-C., Chen W.-P., Chi T.-L., Kuo T.-F., Lee S.-S., Cheng J.-T., Su M.-J. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 2007;80:1713\u20131720. doi: 10.1016/j.lfs.2007.02.002.", "ArticleIdList": ["10.1016/j.lfs.2007.02.002", "17346750"]}, {"Citation": "Palsamy P., Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother. 2008;62:598\u2013605. doi: 10.1016/j.biopha.2008.06.037.", "ArticleIdList": ["10.1016/j.biopha.2008.06.037", "18675532"]}, {"Citation": "Penumathsa S.V., Thirunavukkarasu M., Zhan L., Maulik G., Menon V.P., Bagchi D., Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell Mol. Med. 2008;12:2350\u20132361. doi: 10.1111/j.1582-4934.2008.00251.x.", "ArticleIdList": ["10.1111/j.1582-4934.2008.00251.x", "PMC4514113", "18266981"]}, {"Citation": "Palsamy P., Subramanian S. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin\u2013nicotinamide-induced diabetic rats. Chem. Biol. Interact. 2009;179:356\u2013362. doi: 10.1016/j.cbi.2008.11.008.", "ArticleIdList": ["10.1016/j.cbi.2008.11.008", "19059388"]}, {"Citation": "Ramadori G., Gautron L., Fujikawa T., Vianna C.R., Elmquist J.K., Coppari R. Central administration of resveratrol improves diet-induced diabetes. Endocrinology. 2009;150:5326\u20135333. doi: 10.1210/en.2009-0528.", "ArticleIdList": ["10.1210/en.2009-0528", "PMC2795706", "19819963"]}, {"Citation": "Palsamy P., Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic \u03b2-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol. 2010;224:423\u2013432. doi: 10.1002/jcp.22138.", "ArticleIdList": ["10.1002/jcp.22138", "20333650"]}, {"Citation": "Dao T.-M.A., Waget A., Klopp P., Serino M., Vachoux C., Pechere L., Drucker D.J., Champion S., Barth\u00e9lemy S., Barra Y., Burcelin R., S\u00e9r\u00e9e E. Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which Contributes to the glycemic control. PLoS One. 2011;6 doi: 10.1371/journal.pone.0020700.", "ArticleIdList": ["10.1371/journal.pone.0020700", "PMC3108962", "21673955"]}, {"Citation": "Labb\u00e9 A., Garand C., Cogger V.C., Paquet E.R., Desbiens M., Le Couteur D.G., Lebel M. Resveratrol improves insulin resistance hyperglycemia and Hepatosteatosis but not Hypertriglyceridemia, inflammation, and Life span in a mouse model for Werner syndrome. J. Gerontol. Ser. A. 2011;66A:264\u2013278. doi: 10.1093/gerona/glq184.", "ArticleIdList": ["10.1093/gerona/glq184", "20974729"]}, {"Citation": "Lee S.-M., Yang H., Tartar D.M., Gao B., Luo X., Ye S.Q., Zaghouani H., Fang D. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia. 2011;54:1136\u20131146. doi: 10.1007/s00125-011-2064-1.", "ArticleIdList": ["10.1007/s00125-011-2064-1", "PMC4036531", "21340626"]}, {"Citation": "Minakawa M., Kawano A., Miura Y., Yagasaki K. Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic \u03b2-cells. J. Clin. Biochem. Nutr. 2011;48:237\u2013244.", "ArticleIdList": ["PMC3082080", "21562645"]}, {"Citation": "Mohamad Shahi M., Haidari F., Shiri M.R. Comparison of effect of resveratrol and vanadium on diabetes related dyslipidemia and hyperglycemia in streptozotocin induced diabetic rats. Adv. Pharm. Bull. EISSN. 2011;2251\u20137308 doi: 10.5681/APB.2011.012.", "ArticleIdList": ["10.5681/APB.2011.012", "PMC3845977", "24312761"]}, {"Citation": "Sharma S., Misra C.S., Arumugam S., Roy S., Shah V., Davis J.A., Shirumalla R.K., Ray A. Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytother Res. 2011;25:67\u201373. doi: 10.1002/ptr.3221.", "ArticleIdList": ["10.1002/ptr.3221", "20623590"]}, {"Citation": "Do G.-M., Jung U.J., Park H.-J., Kwon E.-Y., Jeon S.-M., McGregor R.A., Choi M.-S. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol. Nutr. Food Res. 2012;56:1282\u20131291. doi: 10.1002/mnfr.201200067.", "ArticleIdList": ["10.1002/mnfr.201200067", "22715031"]}, {"Citation": "Ku C.R., Lee H.J., Kim S.K., Lee E.Y., Lee M.-K., Lee E.J. Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic \u03b2-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr. J. 2011:1111040641. 1111040641.", "ArticleIdList": ["22068111"]}, {"Citation": "Lee Y.-E., Kim J.-W., Lee E.-M., Ahn Y.-B., Song K.-H., Yoon K.-H., Kim H.-W., Park C.-W., Li G., Liu Z., Ko S.-H. Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice. PLoS One. 2012;7 doi: 10.1371/journal.pone.0050412.", "ArticleIdList": ["10.1371/journal.pone.0050412", "PMC3511555", "23226280"]}, {"Citation": "Ramar M., Manikandan B., Raman T., Priyadarsini A., Palanisamy S., Velayudam M., Munusamy A., Marimuthu Prabhu N., Vaseeharan B. Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur. J. Pharmacol. 2012;690:226\u2013235. doi: 10.1016/j.ejphar.2012.05.019.", "ArticleIdList": ["10.1016/j.ejphar.2012.05.019", "22659112"]}, {"Citation": "Cheng A.-S., Cheng Y.-H., Lee C.-Y., Chung C.-Y., Chang W.-C. Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo. Nutrients. 2015;7:2850\u20132865. doi: 10.3390/nu7042850.", "ArticleIdList": ["10.3390/nu7042850", "PMC4425177", "25884658"]}, {"Citation": "Lalitha V., Korah M.C., Sengottuvel S., Sivakumar T. Antidiabetic and antioxidant activity of resveratrol and Vitamin-C combination on streptozotocin induced diabetic rats. Int J Pharm Pharm Sci. 2015;7:455\u2013458."}, {"Citation": "Yao L., Wan J., Li H., Ding J., Wang Y., Wang X., Li M. Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Reprod. Biol. Endocrinol. 2015;13:118. doi: 10.1186/s12958-015-0114-0.", "ArticleIdList": ["10.1186/s12958-015-0114-0", "PMC4635591", "26542478"]}, {"Citation": "Kaur G., Padiya R., Adela R., Putcha U.K., Reddy G.S., Reddy B.R., Kumar K.P., Chakravarty S., Banerjee S.K. Garlic and resveratrol attenuate diabetic complications, loss of \u03b2-cells, pancreatic and hepatic oxidative stress in streptozotocin-induced diabetic rats. Front. Pharmacol. 2016;7 doi: 10.3389/fphar.2016.00360.", "ArticleIdList": ["10.3389/fphar.2016.00360", "PMC5061813", "27790139"]}, {"Citation": "Rehman K., Saeed K., Munawar S.M., Akash M.S.H. Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model. Biomed. Pharmacother. 2018;102:140\u2013146. doi: 10.1016/j.biopha.2018.03.050.", "ArticleIdList": ["10.1016/j.biopha.2018.03.050", "29550637"]}, {"Citation": "Ahmad M., Gani A. Development of novel functional snacks containing nano-encapsulated resveratrol with anti-diabetic, anti-obesity and antioxidant properties. Food Chem. 2021;352", "ArticleIdList": ["33691210"]}, {"Citation": "Wang W., Liu Z., Kong F., He L., Fang L., Shu Q. Quantitative analysis of resveratrol derivatives in the seed coats of tree peonies and their hypoglycemic activities in vitro/vivo. Food Funct. 2022;13:846\u2013856.", "ArticleIdList": ["34989366"]}, {"Citation": "Pegah A., Khodadadi I., Mirzaei F., Tayebinia H., Abbasi E. Simultaneous effect of resveratrol and Probiotics on insulin resistance and glucagon-like peptide (GLP-1) levels in diabetic rats. J. Babol Univ. Med. Sci. 2021;23:337\u2013344."}, {"Citation": "Pegah A., Abbasi-Oshaghi E., Khodadadi I., Mirzaei F., Tayebinia H. Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metab. Open. 2021;10", "ArticleIdList": ["PMC8091914", "33997755"]}]}], "History": [{"Year": "2024", "Month": "1", "Day": "22"}, {"Year": "2024", "Month": "4", "Day": "3"}, {"Year": "2024", "Month": "4", "Day": "14"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "3", "Minute": "51"}, {"Year": "2024", "Month": "4", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["38694079", "PMC11061711", "10.1016/j.heliyon.2024.e29718", "S2405-8440(24)05749-9"]}}]}